<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">

<head>
  <meta charset="utf-8"/>
  <meta name="viewport" content="width=device-width, initial-scale=1"/>
  <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1"/>
  <meta name="generator" content="distill" />

  <style type="text/css">
  /* Hide doc at startup (prevent jankiness while JS renders/transforms) */
  body {
    visibility: hidden;
  }
  </style>

 <!--radix_placeholder_import_source-->
 <!--/radix_placeholder_import_source-->

<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ad0000; } /* Alert */
code span.an { color: #5e5e5e; } /* Annotation */
code span.at { } /* Attribute */
code span.bn { color: #ad0000; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007ba5; } /* ControlFlow */
code span.ch { color: #20794d; } /* Char */
code span.cn { color: #8f5902; } /* Constant */
code span.co { color: #5e5e5e; } /* Comment */
code span.cv { color: #5e5e5e; font-style: italic; } /* CommentVar */
code span.do { color: #5e5e5e; font-style: italic; } /* Documentation */
code span.dt { color: #ad0000; } /* DataType */
code span.dv { color: #ad0000; } /* DecVal */
code span.er { color: #ad0000; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #ad0000; } /* Float */
code span.fu { color: #4758ab; } /* Function */
code span.im { } /* Import */
code span.in { color: #5e5e5e; } /* Information */
code span.kw { color: #007ba5; } /* Keyword */
code span.op { color: #5e5e5e; } /* Operator */
code span.ot { color: #007ba5; } /* Other */
code span.pp { color: #ad0000; } /* Preprocessor */
code span.sc { color: #5e5e5e; } /* SpecialChar */
code span.ss { color: #20794d; } /* SpecialString */
code span.st { color: #20794d; } /* String */
code span.va { color: #111111; } /* Variable */
code span.vs { color: #20794d; } /* VerbatimString */
code span.wa { color: #5e5e5e; font-style: italic; } /* Warning */
</style>

<style>
  div.csl-bib-body { }
  div.csl-entry {
    clear: both;
    }
  .hanging div.csl-entry {
    margin-left:2em;
    text-indent:-2em;
  }
  div.csl-left-margin {
    min-width:2em;
    float:left;
  }
  div.csl-right-inline {
    margin-left:2em;
    padding-left:1em;
  }
  div.csl-indent {
    margin-left: 2em;
  }
</style>

  <!--radix_placeholder_meta_tags-->
  <title>KYS study group: 11장 4절: 클로자핀 투여 전략</title>

  <meta property="description" itemprop="description" content="Treatment Strategies using Clozapine"/>



  <!--  https://developers.facebook.com/docs/sharing/webmasters#markup -->
  <meta property="og:title" content="KYS study group: 11장 4절: 클로자핀 투여 전략"/>
  <meta property="og:type" content="article"/>
  <meta property="og:description" content="Treatment Strategies using Clozapine"/>
  <meta property="og:locale" content="en_US"/>
  <meta property="og:site_name" content="KYS study group"/>

  <!--  https://dev.twitter.com/cards/types/summary -->
  <meta property="twitter:card" content="summary"/>
  <meta property="twitter:title" content="KYS study group: 11장 4절: 클로자핀 투여 전략"/>
  <meta property="twitter:description" content="Treatment Strategies using Clozapine"/>

  <!--/radix_placeholder_meta_tags-->
  
  <meta name="citation_reference" content="citation_title=An algorithm-based approach to first-episode schizophrenia: Response rates over 3 prospective antipsychotic trials with a retrospective data analysis;citation_publication_date=2011;citation_volume=72;citation_doi=10.4088/JCP.09m05785yel;citation_issn=0160-6689;citation_author=O. Agid;citation_author=T. Arenovich;citation_author=G. Sajeev;citation_author=R. B. Zipursky;citation_author=S. Kapur;citation_author=G. Foussias;citation_author=G. Remington"/>
  <meta name="citation_reference" content="citation_title=The international suicide prevention trial (interSePT): Rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients;citation_publication_date=2004;citation_volume=30;citation_issn=1745-1701;citation_author=Larry Alphs;citation_author=Ravi Anand;citation_author=M Zahur Islam;citation_author=Herbert Y Meltzer;citation_author=John M Kane;citation_author=Ranga Krishnan;citation_author=Alan I Green;citation_author=Steven Potkin;citation_author=Guy Chouinard;citation_author=Jean-Pierre Lindenmayer"/>
  <meta name="citation_reference" content="citation_title=Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders?;citation_publication_date=2015;citation_volume=230;citation_doi=10.1016/j.psychres.2015.10.036;citation_issn=0165-1781;citation_author=V. M. Anderson;citation_author=M. E. McIlwain;citation_author=R. R. Kydd;citation_author=B. R. Russell"/>
  <meta name="citation_reference" content="citation_title=Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial;citation_publication_date=2008;citation_volume=41;citation_issn=0176-3679;citation_author=H-J Assion;citation_author=H Reinbold;citation_author=S Lemanski;citation_author=M Basilowski;citation_author=G Juckel"/>
  <meta name="citation_reference" content="citation_title=Does the addition of a second antipsychotic drug improve clozapine treatment?;citation_publication_date=2009;citation_volume=35;citation_issn=1745-1701;citation_author=Corrado Barbui;citation_author=Alessandra Signoretti;citation_author=Serena Mule;citation_author=Marianna Boso;citation_author=Andrea Cipriani"/>
  <meta name="citation_reference" content="citation_title=Adjunctive second-generation antipsychotics for specific symptom domains of schizophrenia resistant to clozapine: A meta-analysis;citation_publication_date=2019;citation_volume=108;citation_issn=0022-3956;citation_author=Francesco Bartoli;citation_author=Cristina Crocamo;citation_author=Carmen Di Brita;citation_author=Giovanni Esposito;citation_author=Tommaso Innocenzo Tabacchi;citation_author=Enrica Verrengia;citation_author=Massimo Clerici;citation_author=Giuseppe Carra"/>
  <meta name="citation_reference" content="citation_title=Early intervention in psychosis: The critical period hypothesis;citation_publication_date=1998;citation_volume=172;citation_issn=0007-1250;citation_author=Max Birchwood;citation_author=Pauline Todd;citation_author=Chris Jackson"/>
  <meta name="citation_reference" content="citation_title=Worsening of psychotic symptoms in schizophrenia with addition of lamotrigine: A case report;citation_publication_date=2005;citation_volume=78;citation_issn=0920-9964;citation_author=Yiu-Chung Chan;citation_author=Karla M Miller;citation_author=Natalie Shaheen;citation_author=Nicholas A Votolato;citation_author=Mary Beth Hankins"/>
  <meta name="citation_reference" content="citation_title=Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: An 8-week, randomized, double-blind, placebo-controlled trial;citation_publication_date=2008;citation_volume=69;citation_issn=0160-6689;citation_author=Jae Seung Chang;citation_author=Yongmin Ahn;citation_author=Hye Jean Park;citation_author=Kyu Young Lee;citation_author=Se Hyun Kim;citation_author=Unggu Kang;citation_author=Yong Sik Kim"/>
  <meta name="citation_reference" content="citation_title=Antipsychotic treatment resistance in first-episode psychosis: Prevalence, subtypes and predictors;citation_publication_date=2017;citation_volume=47;citation_doi=10.1017/s0033291717000435;citation_issn=0033-2917;citation_author=A. Demjaha;citation_author=J. M. Lappin;citation_author=D. Stahl;citation_author=M. X. Patel;citation_author=J. H. MacCabe;citation_author=O. D. Howes;citation_author=M. Heslin;citation_author=U. A. Reininghaus;citation_author=K. Donoghue;citation_author=B. Lomas;citation_author=M. Charalambides;citation_author=A. Onyejiaka;citation_author=P. Fearon;citation_author=P. Jones;citation_author=G. Doody;citation_author=C. Morgan;citation_author=P. Dazzan;citation_author=R. M. Murray"/>
  <meta name="citation_reference" content="citation_title=Resistance is not futile: Treatment-refractory schizophrenia - overview, evaluation and treatment;citation_publication_date=2019;citation_volume=20;citation_doi=10.1080/14656566.2018.1543409;citation_issn=1465-6566;citation_author=J. Faden;citation_author=L. Citrome"/>
  <meta name="citation_reference" content="citation_title=A systematic review of the evidence of clozapine’s anti-aggressive effects;citation_publication_date=2012;citation_volume=15;citation_issn=1469-5111;citation_author=Catherine Frogley;citation_author=David Taylor;citation_author=Geoff Dickens;citation_author=Marco Picchioni"/>
  <meta name="citation_reference" content="citation_title=Early intervention in psychosis;citation_publication_date=2000;citation_volume=24;citation_issn=0955-6036;citation_author=Philippa Garety;citation_author=Suzanne Jolley"/>
  <meta name="citation_reference" content="citation_title=Lamotrigine may be an effective treatment for clozapine resistant schizophrenia;citation_publication_date=2009;citation_volume=12;citation_issn=1468-960X;citation_author=Donald C Goff"/>
  <meta name="citation_reference" content="citation_title=Suicidal risk during treatment with clozapine: A meta-analysis;citation_publication_date=2005;citation_volume=73;citation_issn=0920-9964;citation_author=John Hennen;citation_author=Ross J Baldessarini"/>
  <meta name="citation_reference" content="citation_title=Clozapine alone versus clozapine and risperidone with refractory schizophrenia;citation_publication_date=2006;citation_volume=354;citation_issn=0028-4793;citation_author=William G Honer;citation_author=Allen E Thornton;citation_author=Eric YH Chen;citation_author=Raymond CK Chan;citation_author=Jessica OY Wong;citation_author=Andrea Bergmann;citation_author=Peter Falkai;citation_author=Edith Pomarol-Clotet;citation_author=Peter J McKenna;citation_author=Emmanuel Stip"/>
  <meta name="citation_reference" content="citation_title=Clozapine augmented with risperidone in the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial;citation_publication_date=2005;citation_volume=162;citation_issn=0002-953X;citation_author=Richard C Josiassen;citation_author=Ashok Joseph;citation_author=Eva Kohegyi;citation_author=Sudhir Stokes;citation_author=Mahmood Dadvand;citation_author=Wynn Wynn Paing;citation_author=Rita A Shaughnessy"/>
  <meta name="citation_reference" content="citation_title=Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine;citation_publication_date=1988;citation_volume=45;citation_issn=0003-990X;citation_author=John Kane;citation_author=Gilbert Honigfeld;citation_author=Jack Singer;citation_author=Herbert Meltzer"/>
  <meta name="citation_reference" content="citation_title=Clinical guidance on the identification and management of treatment-resistant schizophrenia;citation_publication_date=2019;citation_volume=80;citation_doi=10.4088/JCP.18com12123;citation_issn=0160-6689;citation_author=J. M. Kane;citation_author=O. Agid;citation_author=M. L. Baldwin;citation_author=O. Howes;citation_author=J. P. Lindenmayer;citation_author=S. Marder;citation_author=M. Olfson;citation_author=S. G. Potkin;citation_author=C. U. Correll"/>
  <meta name="citation_reference" content="citation_title=Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction;citation_publication_date=1985;citation_volume=146;citation_issn=0007-1250;citation_author=T Kolakowska;citation_author=AO Williams;citation_author=M Ardern;citation_author=MA Reveley;citation_author=K Jambor;citation_author=MG Gelder;citation_author=BM Mandelbrote"/>
  <meta name="citation_reference" content="citation_title=Two distinct patterns of treatment resistance: Clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses;citation_publication_date=2016;citation_volume=46;citation_doi=10.1017/s0033291716002014;citation_issn=0033-2917;citation_author=J. Lally;citation_author=O. Ajnakina;citation_author=M. Di Forti;citation_author=A. Trotta;citation_author=A. Demjaha;citation_author=A. Kolliakou;citation_author=V. Mondelli;citation_author=T. Reis Marques;citation_author=C. Pariante;citation_author=P. Dazzan;citation_author=S. S. Shergil;citation_author=O. D. Howes;citation_author=A. S. David;citation_author=J. H. MacCabe;citation_author=F. Gaughran;citation_author=R. M. Murray"/>
  <meta name="citation_reference" content="citation_title=Positive symptoms are associated with clinicians’ global impression in treatment-resistant schizophrenia;citation_publication_date=2015;citation_volume=35;citation_issn=0271-0749;citation_author=Jimmy Lee;citation_author=Gagan Fervaha;citation_author=Hiroyoshi Takeuchi;citation_author=Valerie Powell;citation_author=Gary Remington"/>
  <meta name="citation_reference" content="citation_title=Optimal dose of neuroleptic in acute schizophrenia: A controlled study of the neuroleptic threshold and higher haloperidol dose;citation_publication_date=1991;citation_volume=48;citation_issn=0003-990X;citation_author=Joseph P McEvoy;citation_author=Gerard E Hogarty;citation_author=Sandra Steingard"/>
  <meta name="citation_reference" content="citation_title=Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study;citation_publication_date=2007;citation_volume=31;citation_issn=0278-5846;citation_author=Charalampos I Mitsonis;citation_author=Nikolaos P Dimopoulos;citation_author=Panagiotis A Mitropoulos;citation_author=Evangelia G Kararizou;citation_author=Alexandra N Katsa;citation_author=Fivos E Tsakiris;citation_author=Maria Nefeli E Katsanou"/>
  <meta name="citation_reference" content="citation_title=Schizophrenia: When clozapine fails;citation_publication_date=2015;citation_volume=28;citation_issn=0951-7367;citation_author=Seiya Miyamoto;citation_author=Lars Fredrik Jarskog;citation_author=W Wolfgang Fleischhacker"/>
  <meta name="citation_reference" content="citation_title=Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia;citation_publication_date=2006;citation_volume=29;citation_doi=10.1097/00002826-200601000-00009;citation_issn=0362-5664 (Print)&#10;0362-5664;citation_author=F. Mouaffak;citation_author=C. Tranulis;citation_author=R. Gourevitch;citation_author=M. F. Poirier;citation_author=S. Douki;citation_author=J. P. Olié;citation_author=H. Lôo;citation_author=D. Gourion"/>
  <meta name="citation_reference" content="citation_title=Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine;citation_publication_date=2014;citation_volume=15;citation_issn=1465-6566;citation_author=Maria Rosaria A Muscatello;citation_author=Antonio Bruno;citation_author=Pasquale De Fazio;citation_author=Cristina Segura-Garcia;citation_author=Gianluca Pandolfo;citation_author=Rocco Zoccali"/>
  <meta name="citation_reference" content="citation_title=Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine: A meta-analysis;citation_publication_date=2007;citation_volume=27;citation_issn=0271-0749;citation_author=Carol Paton;citation_author=Craig Whittington;citation_author=Thomas R Barnes"/>
  <meta name="citation_reference" content="citation_title=Clozapine’s role in the treatment of first-episode schizophrenia;citation_publication_date=2013;citation_volume=170;citation_doi=10.1176/appi.ajp.2012.12060778;citation_issn=0002-953x;citation_author=G. Remington;citation_author=O. Agid;citation_author=G. Foussias;citation_author=M. Hahn;citation_author=N. Rao;citation_author=M. Sinyor"/>
  <meta name="citation_reference" content="citation_title=Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: A network meta-analysis;citation_publication_date=2016;citation_volume=73;citation_issn=2168-622X;citation_author=Myrto T Samara;citation_author=Markus Dold;citation_author=Myrsini Gianatsi;citation_author=Adriani Nikolakopoulou;citation_author=Bartosz Helfer;citation_author=Georgia Salanti;citation_author=Stefan Leucht"/>
  <meta name="citation_reference" content="citation_title=Clozapine v. First-and second-generation antipsychotics in treatment-refractory schizophrenia: Systematic review and meta-analysis;citation_publication_date=2016;citation_volume=209;citation_issn=0007-1250;citation_author=Dan Siskind;citation_author=Lara McCartney;citation_author=Romi Goldschlager;citation_author=Steve Kisely"/>
  <meta name="citation_reference" content="citation_title=Clozapine response rates among people with treatment-resistant schizophrenia: Data from a systematic review and meta-analysis;citation_publication_date=2017;citation_volume=62;citation_doi=10.1177/0706743717718167;citation_issn=0706-7437 (Print)&#10;0706-7437;citation_author=D. Siskind;citation_author=V. Siskind;citation_author=S. Kisely"/>
  <meta name="citation_reference" content="citation_title=Augmentation of clozapine with a second antipsychotic–a meta‐analysis;citation_publication_date=2012;citation_volume=125;citation_issn=0001-690X;citation_author=DM Taylor;citation_author=L Smith;citation_author=SH Gee;citation_author=Jimmi Nielsen"/>
  <meta name="citation_reference" content="citation_title=Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia;citation_publication_date=2015;citation_volume=30;citation_issn=0268-1315;citation_author=Alp Üçok;citation_author=Uğur Çikrikçili;citation_author=Sercan Karabulut;citation_author=Ada Salaj;citation_author=Meliha Öztürk;citation_author=Öznur Tabak;citation_author=Rümeysa Durak"/>
  <meta name="citation_reference" content="citation_title=Natural course of schizophrenic disorders: A 15-year followup of a dutch incidence cohort;citation_publication_date=1998;citation_volume=24;citation_issn=1745-1701;citation_author=Durk Wiersma;citation_author=Fokko J Nienhuis;citation_author=Cees J Slooff;citation_author=Robert Giel"/>
  <meta name="citation_reference" content="citation_title=Mortality and self-harm in association with clozapine in treatment-resistant schizophrenia;citation_publication_date=2017;citation_volume=174;citation_doi=10.1176/appi.ajp.2017.16091097;citation_issn=0002-953x;citation_author=T. Wimberley;citation_author=J. H. MacCabe;citation_author=T. M. Laursen;citation_author=H. J. Sørensen;citation_author=A. Astrup;citation_author=H. T. Horsdal;citation_author=C. Gasse;citation_author=H. Støvring"/>
  <meta name="citation_reference" content="citation_title=Correlation between delay in initiating clozapine and symptomatic improvement;citation_publication_date=2015;citation_volume=168;citation_issn=1573-2509;citation_author=Yuji Yada;citation_author=Bunta Yoshimura;citation_author=Yoshiki Kishi"/>
  <meta name="citation_reference" content="citation_title=The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study;citation_publication_date=2017;citation_volume=250;citation_issn=0165-1781;citation_author=Bunta Yoshimura;citation_author=Yuji Yada;citation_author=Ryuhei So;citation_author=Manabu Takaki;citation_author=Norihito Yamada"/>
  <meta name="citation_reference" content="citation_title=The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis;citation_publication_date=2009;citation_volume=109;citation_doi=10.1016/j.schres.2009.01.002;citation_author=Jari Tiihonen;citation_author=Kristian Wahlbeck;citation_author=Vesa Kiviniemi"/>
  <meta name="citation_reference" content="citation_title=A quantitative analysis of antipsychotic prescribing trends for the treatment of schizophrenia in England and Wales;citation_publication_date=2018;citation_volume=9;citation_doi=10.1177/2054270418758570;citation_author=Rossela Roberts;citation_author=Abigail Neasham;citation_author=Chania Lambrinudi;citation_author=Afshan Khan"/>
  <meta name="citation_reference" content="citation_title=Clozapine: a review of clinical practice guidelines and prescribing trends;citation_publication_date=2014;citation_volume=14;citation_doi=10.1186/1471-244x-14-102;citation_author=Stephanie Warnez;citation_author=Silvia Alessi-Severini"/>
  <meta name="citation_reference" content="citation_title=Clozapine: Is Now the Time for More Clinicians to Adopt This Orphan?;citation_publication_date=2014;citation_volume=19;citation_doi=10.1017/s1092852914000418;citation_author=Stephen M. Stahl"/>
  <meta name="citation_reference" content="citation_title=Seizure Associated with Clozapine: Incidence, Etiology, and Management;citation_publication_date=2014;citation_volume=29;citation_doi=10.1007/s40263-014-0222-y;citation_author=Andrew M. Williams;citation_author=Susie H. Park"/>
  <meta name="citation_reference" content="citation_title=Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia;citation_publication_date=2014;citation_doi=10.2147/ndt.s69784;citation_author=Yuka Kikuchi;citation_author=Wataru Sato;citation_author=Keiichiro Ataka;citation_author=Kiwamu Yagisawa;citation_author=Yuki Omori;citation_author=Takashi Kanbayashi;citation_author=Tetsuo Shimizu"/>
  <meta name="citation_reference" content="citation_title=Are we using excessive neuroleptics? An argument for systematic neuroleptic dose reduction in stable patients with schizophrenia with specific reference to clozapine;citation_publication_date=2010;citation_volume=22;citation_doi=10.3109/09540261.2010.482558;citation_author=Sami Yamin;citation_author=Krishna Vaddadi"/>
  <meta name="citation_reference" content="citation_title=The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine;citation_publication_date=2000;citation_volume=22;citation_doi=10.1016/s0149-2918(00)80082-x;citation_author=Martin R.K. Dossenbach;citation_author=Jean-Noel Beuzen;citation_author=Moshe Avnon;citation_author=Robert H. Belmaker;citation_author=Avner Elizur;citation_author=Mordechai Mark;citation_author=Hanan Munitz;citation_author=Michael Schneidman;citation_author=David Shoshani;citation_author=Petra Kratky;citation_author=Starr Lee Grundy;citation_author=Gary D. Tollefson"/>
  <meta name="citation_reference" content="citation_title=Effective Switch From Clozapine to Aripiprazole in Treatment-Resistant Schizophrenia and Comorbid Alcohol Use Disorder;citation_publication_date=2017;citation_volume=37;citation_doi=10.1097/jcp.0000000000000794;citation_author=Robert J. Feeley;citation_author=Bachaar Arnaout;citation_author=Gihyun Yoon"/>
  <meta name="citation_reference" content="citation_title=Clozapine augmentation strategies  a systematic meta-review of available evidence. Treatment options for clozapine resistance;citation_publication_date=2019;citation_volume=33;citation_doi=10.1177/0269881118822171;citation_author=Elias Wagner;citation_author=Lisa Löhrs;citation_author=Dan Siskind;citation_author=William G Honer;citation_author=Peter Falkai;citation_author=Alkomiet Hasan"/>
  <meta name="citation_reference" content="citation_title=Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia;citation_publication_date=2019;citation_volume=76;citation_doi=10.1001/jamapsychiatry.2018.4320;citation_author=Jari Tiihonen;citation_author=Heidi Taipale;citation_author=Juha Mehtälä;citation_author=Pia Vattulainen;citation_author=Christoph U. Correll;citation_author=Antti Tanskanen"/>
  <meta name="citation_reference" content="citation_title=Aripiprazole Versus Haloperidol in Combination With Clozapine for Treatment-Resistant Schizophrenia in Routine Clinical Care;citation_publication_date=2011;citation_volume=31;citation_doi=10.1097/jcp.0b013e318219cba3;citation_author=Corrado Barbui;citation_author=Simone Accordini;citation_author=Michela Nosè;citation_author=Scott Stroup;citation_author=Marianna Purgato;citation_author=Francesca Girlanda;citation_author=Eleonora Esposito;citation_author=Antonio Veronese;citation_author=Michele Tansella;citation_author=Andrea Cipriani"/>
  <meta name="citation_reference" content="citation_title=Aripiprazole Versus Haloperidol in Combination With Clozapine for Treatment-Resistant Schizophrenia;citation_publication_date=2013;citation_volume=33;citation_doi=10.1097/jcp.0b013e318296884f;citation_author=Andrea Cipriani;citation_author=Simone Accordini;citation_author=Michela Nosè;citation_author=Marianna Purgato;citation_author=Francesca Girlanda;citation_author=Michele Tansella;citation_author=Corrado Barbui"/>
  <meta name="citation_reference" content="citation_title=Effects of lamotrigine on PCP-evoked elevations in monoamine levels in the medial prefrontal cortex of freely moving rats;citation_publication_date=2010;citation_volume=25;citation_doi=10.1177/0269881110385598;citation_author=Davide Quarta;citation_author=Charles H Large"/>
  <meta name="citation_reference" content="citation_title=The potential role of lamotrigine in schizophrenia;citation_publication_date=2005;citation_volume=181;citation_doi=10.1007/s00213-005-0020-9;citation_author=Charles H. Large;citation_author=Elizabeth L. Webster;citation_author=Donald C. Goff"/>
  <meta name="citation_reference" content="citation_title=Clozapine Plus Lamotrigine in Treatment-Resistant Schizophrenia;citation_publication_date=1999;citation_volume=56;citation_doi=10.1001/archpsyc.56.10.950;citation_author=Serdar M. Dursun;citation_author=Diane McIntosh;citation_author=Heather Milliken"/>
  <meta name="citation_reference" content="citation_title=Clozapine augmentation with antiepileptic drugs for treatment-resistant schizophrenia;citation_publication_date=2017;citation_volume=78;citation_doi=10.4088/jcp.16r10782;citation_author=Wei Zheng;citation_author=Yu-Tao Xiang;citation_author=Xin-Hu Yang;citation_author=Ying-Qiang Xiang;citation_author=Jose Leon"/>
  <meta name="citation_reference" content="citation_title=Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review;citation_publication_date=2011;citation_volume=38;citation_doi=10.1093/schbul/sbr004;citation_author=Iris E. Sommer;citation_author=Marieke J. H. Begemann;citation_author=Anke Temmerman;citation_author=Stefan Leucht"/>
  <meta name="citation_reference" content="citation_title=When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity;citation_publication_date=2017;citation_volume=8;citation_doi=10.1177/2045125317737003;citation_author=Penelope Lowe;citation_author=Amir Krivoy;citation_author=Lilla Porffy;citation_author=Erna Henriksdottir;citation_author=Whiskey Eromona;citation_author=Sukhwinder S. Shergill"/>
  <!--radix_placeholder_rmarkdown_metadata-->

  <script type="text/json" id="radix-rmarkdown-metadata">
  {"type":"list","attributes":{"names":{"type":"character","attributes":{},"value":["title","description","bibliography","link-citation"]}},"value":[{"type":"character","attributes":{},"value":["11장 4절: 클로자핀 투여 전략"]},{"type":"character","attributes":{},"value":["Treatment Strategies using Clozapine"]},{"type":"character","attributes":{},"value":["references/11-01.bib"]},{"type":"logical","attributes":{},"value":[true]}]}
  </script>
  <!--/radix_placeholder_rmarkdown_metadata-->
  <!--radix_placeholder_navigation_in_header-->
  <meta name="distill:offset" content=""/>

  <script type="application/javascript">

    window.headroom_prevent_pin = false;

    window.document.addEventListener("DOMContentLoaded", function (event) {

      // initialize headroom for banner
      var header = $('header').get(0);
      var headerHeight = header.offsetHeight;
      var headroom = new Headroom(header, {
        tolerance: 5,
        onPin : function() {
          if (window.headroom_prevent_pin) {
            window.headroom_prevent_pin = false;
            headroom.unpin();
          }
        }
      });
      headroom.init();
      if(window.location.hash)
        headroom.unpin();
      $(header).addClass('headroom--transition');

      // offset scroll location for banner on hash change
      // (see: https://github.com/WickyNilliams/headroom.js/issues/38)
      window.addEventListener("hashchange", function(event) {
        window.scrollTo(0, window.pageYOffset - (headerHeight + 25));
      });

      // responsive menu
      $('.distill-site-header').each(function(i, val) {
        var topnav = $(this);
        var toggle = topnav.find('.nav-toggle');
        toggle.on('click', function() {
          topnav.toggleClass('responsive');
        });
      });

      // nav dropdowns
      $('.nav-dropbtn').click(function(e) {
        $(this).next('.nav-dropdown-content').toggleClass('nav-dropdown-active');
        $(this).parent().siblings('.nav-dropdown')
           .children('.nav-dropdown-content').removeClass('nav-dropdown-active');
      });
      $("body").click(function(e){
        $('.nav-dropdown-content').removeClass('nav-dropdown-active');
      });
      $(".nav-dropdown").click(function(e){
        e.stopPropagation();
      });
    });
  </script>

  <style type="text/css">

  /* Theme (user-documented overrideables for nav appearance) */

  .distill-site-nav {
    color: rgba(255, 255, 255, 0.8);
    background-color: #0F2E3D;
    font-size: 15px;
    font-weight: 300;
  }

  .distill-site-nav a {
    color: inherit;
    text-decoration: none;
  }

  .distill-site-nav a:hover {
    color: white;
  }

  @media print {
    .distill-site-nav {
      display: none;
    }
  }

  .distill-site-header {

  }

  .distill-site-footer {

  }


  /* Site Header */

  .distill-site-header {
    width: 100%;
    box-sizing: border-box;
    z-index: 3;
  }

  .distill-site-header .nav-left {
    display: inline-block;
    margin-left: 8px;
  }

  @media screen and (max-width: 768px) {
    .distill-site-header .nav-left {
      margin-left: 0;
    }
  }


  .distill-site-header .nav-right {
    float: right;
    margin-right: 8px;
  }

  .distill-site-header a,
  .distill-site-header .title {
    display: inline-block;
    text-align: center;
    padding: 14px 10px 14px 10px;
  }

  .distill-site-header .title {
    font-size: 18px;
    min-width: 150px;
  }

  .distill-site-header .logo {
    padding: 0;
  }

  .distill-site-header .logo img {
    display: none;
    max-height: 20px;
    width: auto;
    margin-bottom: -4px;
  }

  .distill-site-header .nav-image img {
    max-height: 18px;
    width: auto;
    display: inline-block;
    margin-bottom: -3px;
  }



  @media screen and (min-width: 1000px) {
    .distill-site-header .logo img {
      display: inline-block;
    }
    .distill-site-header .nav-left {
      margin-left: 20px;
    }
    .distill-site-header .nav-right {
      margin-right: 20px;
    }
    .distill-site-header .title {
      padding-left: 12px;
    }
  }


  .distill-site-header .nav-toggle {
    display: none;
  }

  .nav-dropdown {
    display: inline-block;
    position: relative;
  }

  .nav-dropdown .nav-dropbtn {
    border: none;
    outline: none;
    color: rgba(255, 255, 255, 0.8);
    padding: 16px 10px;
    background-color: transparent;
    font-family: inherit;
    font-size: inherit;
    font-weight: inherit;
    margin: 0;
    margin-top: 1px;
    z-index: 2;
  }

  .nav-dropdown-content {
    display: none;
    position: absolute;
    background-color: white;
    min-width: 200px;
    border: 1px solid rgba(0,0,0,0.15);
    border-radius: 4px;
    box-shadow: 0px 8px 16px 0px rgba(0,0,0,0.1);
    z-index: 1;
    margin-top: 2px;
    white-space: nowrap;
    padding-top: 4px;
    padding-bottom: 4px;
  }

  .nav-dropdown-content hr {
    margin-top: 4px;
    margin-bottom: 4px;
    border: none;
    border-bottom: 1px solid rgba(0, 0, 0, 0.1);
  }

  .nav-dropdown-active {
    display: block;
  }

  .nav-dropdown-content a, .nav-dropdown-content .nav-dropdown-header {
    color: black;
    padding: 6px 24px;
    text-decoration: none;
    display: block;
    text-align: left;
  }

  .nav-dropdown-content .nav-dropdown-header {
    display: block;
    padding: 5px 24px;
    padding-bottom: 0;
    text-transform: uppercase;
    font-size: 14px;
    color: #999999;
    white-space: nowrap;
  }

  .nav-dropdown:hover .nav-dropbtn {
    color: white;
  }

  .nav-dropdown-content a:hover {
    background-color: #ddd;
    color: black;
  }

  .nav-right .nav-dropdown-content {
    margin-left: -45%;
    right: 0;
  }

  @media screen and (max-width: 768px) {
    .distill-site-header a, .distill-site-header .nav-dropdown  {display: none;}
    .distill-site-header a.nav-toggle {
      float: right;
      display: block;
    }
    .distill-site-header .title {
      margin-left: 0;
    }
    .distill-site-header .nav-right {
      margin-right: 0;
    }
    .distill-site-header {
      overflow: hidden;
    }
    .nav-right .nav-dropdown-content {
      margin-left: 0;
    }
  }


  @media screen and (max-width: 768px) {
    .distill-site-header.responsive {position: relative; min-height: 500px; }
    .distill-site-header.responsive a.nav-toggle {
      position: absolute;
      right: 0;
      top: 0;
    }
    .distill-site-header.responsive a,
    .distill-site-header.responsive .nav-dropdown {
      display: block;
      text-align: left;
    }
    .distill-site-header.responsive .nav-left,
    .distill-site-header.responsive .nav-right {
      width: 100%;
    }
    .distill-site-header.responsive .nav-dropdown {float: none;}
    .distill-site-header.responsive .nav-dropdown-content {position: relative;}
    .distill-site-header.responsive .nav-dropdown .nav-dropbtn {
      display: block;
      width: 100%;
      text-align: left;
    }
  }

  /* Site Footer */

  .distill-site-footer {
    width: 100%;
    overflow: hidden;
    box-sizing: border-box;
    z-index: 3;
    margin-top: 30px;
    padding-top: 30px;
    padding-bottom: 30px;
    text-align: center;
  }

  /* Headroom */

  d-title {
    padding-top: 6rem;
  }

  @media print {
    d-title {
      padding-top: 4rem;
    }
  }

  .headroom {
    z-index: 1000;
    position: fixed;
    top: 0;
    left: 0;
    right: 0;
  }

  .headroom--transition {
    transition: all .4s ease-in-out;
  }

  .headroom--unpinned {
    top: -100px;
  }

  .headroom--pinned {
    top: 0;
  }

  /* adjust viewport for navbar height */
  /* helps vertically center bootstrap (non-distill) content */
  .min-vh-100 {
    min-height: calc(100vh - 100px) !important;
  }

  </style>

  <script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
  <link href="site_libs/font-awesome-5.1.0/css/all.css" rel="stylesheet"/>
  <link href="site_libs/font-awesome-5.1.0/css/v4-shims.css" rel="stylesheet"/>
  <script src="site_libs/headroom-0.9.4/headroom.min.js"></script>
  <script src="site_libs/autocomplete-0.37.1/autocomplete.min.js"></script>
  <script src="site_libs/fuse-6.4.1/fuse.min.js"></script>

  <script type="application/javascript">

  function getMeta(metaName) {
    var metas = document.getElementsByTagName('meta');
    for (let i = 0; i < metas.length; i++) {
      if (metas[i].getAttribute('name') === metaName) {
        return metas[i].getAttribute('content');
      }
    }
    return '';
  }

  function offsetURL(url) {
    var offset = getMeta('distill:offset');
    return offset ? offset + '/' + url : url;
  }

  function createFuseIndex() {

    // create fuse index
    var options = {
      keys: [
        { name: 'title', weight: 20 },
        { name: 'categories', weight: 15 },
        { name: 'description', weight: 10 },
        { name: 'contents', weight: 5 },
      ],
      ignoreLocation: true,
      threshold: 0
    };
    var fuse = new window.Fuse([], options);

    // fetch the main search.json
    return fetch(offsetURL('search.json'))
      .then(function(response) {
        if (response.status == 200) {
          return response.json().then(function(json) {
            // index main articles
            json.articles.forEach(function(article) {
              fuse.add(article);
            });
            // download collections and index their articles
            return Promise.all(json.collections.map(function(collection) {
              return fetch(offsetURL(collection)).then(function(response) {
                if (response.status === 200) {
                  return response.json().then(function(articles) {
                    articles.forEach(function(article) {
                      fuse.add(article);
                    });
                  })
                } else {
                  return Promise.reject(
                    new Error('Unexpected status from search index request: ' +
                              response.status)
                  );
                }
              });
            })).then(function() {
              return fuse;
            });
          });

        } else {
          return Promise.reject(
            new Error('Unexpected status from search index request: ' +
                        response.status)
          );
        }
      });
  }

  window.document.addEventListener("DOMContentLoaded", function (event) {

    // get search element (bail if we don't have one)
    var searchEl = window.document.getElementById('distill-search');
    if (!searchEl)
      return;

    createFuseIndex()
      .then(function(fuse) {

        // make search box visible
        searchEl.classList.remove('hidden');

        // initialize autocomplete
        var options = {
          autoselect: true,
          hint: false,
          minLength: 2,
        };
        window.autocomplete(searchEl, options, [{
          source: function(query, callback) {
            const searchOptions = {
              isCaseSensitive: false,
              shouldSort: true,
              minMatchCharLength: 2,
              limit: 10,
            };
            var results = fuse.search(query, searchOptions);
            callback(results
              .map(function(result) { return result.item; })
            );
          },
          templates: {
            suggestion: function(suggestion) {
              var img = suggestion.preview && Object.keys(suggestion.preview).length > 0
                ? `<img src="${offsetURL(suggestion.preview)}"</img>`
                : '';
              var html = `
                <div class="search-item">
                  <h3>${suggestion.title}</h3>
                  <div class="search-item-description">
                    ${suggestion.description || ''}
                  </div>
                  <div class="search-item-preview">
                    ${img}
                  </div>
                </div>
              `;
              return html;
            }
          }
        }]).on('autocomplete:selected', function(event, suggestion) {
          window.location.href = offsetURL(suggestion.path);
        });
        // remove inline display style on autocompleter (we want to
        // manage responsive display via css)
        $('.algolia-autocomplete').css("display", "");
      })
      .catch(function(error) {
        console.log(error);
      });

  });

  </script>

  <style type="text/css">

  .nav-search {
    font-size: x-small;
  }

  /* Algolioa Autocomplete */

  .algolia-autocomplete {
    display: inline-block;
    margin-left: 10px;
    vertical-align: sub;
    background-color: white;
    color: black;
    padding: 6px;
    padding-top: 8px;
    padding-bottom: 0;
    border-radius: 6px;
    border: 1px #0F2E3D solid;
    width: 180px;
  }


  @media screen and (max-width: 768px) {
    .distill-site-nav .algolia-autocomplete {
      display: none;
      visibility: hidden;
    }
    .distill-site-nav.responsive .algolia-autocomplete {
      display: inline-block;
      visibility: visible;
    }
    .distill-site-nav.responsive .algolia-autocomplete .aa-dropdown-menu {
      margin-left: 0;
      width: 400px;
      max-height: 400px;
    }
  }

  .algolia-autocomplete .aa-input, .algolia-autocomplete .aa-hint {
    width: 90%;
    outline: none;
    border: none;
  }

  .algolia-autocomplete .aa-hint {
    color: #999;
  }
  .algolia-autocomplete .aa-dropdown-menu {
    width: 550px;
    max-height: 70vh;
    overflow-x: visible;
    overflow-y: scroll;
    padding: 5px;
    margin-top: 3px;
    margin-left: -150px;
    background-color: #fff;
    border-radius: 5px;
    border: 1px solid #999;
    border-top: none;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion {
    cursor: pointer;
    padding: 5px 4px;
    border-bottom: 1px solid #eee;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion:last-of-type {
    border-bottom: none;
    margin-bottom: 2px;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item {
    overflow: hidden;
    font-size: 0.8em;
    line-height: 1.4em;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item h3 {
    font-size: 1rem;
    margin-block-start: 0;
    margin-block-end: 5px;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item-description {
    display: inline-block;
    overflow: hidden;
    height: 2.8em;
    width: 80%;
    margin-right: 4%;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item-preview {
    display: inline-block;
    width: 15%;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item-preview img {
    height: 3em;
    width: auto;
    display: none;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion .search-item-preview img[src] {
    display: initial;
  }

  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion.aa-cursor {
    background-color: #eee;
  }
  .algolia-autocomplete .aa-dropdown-menu .aa-suggestion em {
    font-weight: bold;
    font-style: normal;
  }

  </style>


  <!--/radix_placeholder_navigation_in_header-->
  <!--radix_placeholder_distill-->

  <style type="text/css">

  body {
    background-color: white;
  }

  .pandoc-table {
    width: 100%;
  }

  .pandoc-table>caption {
    margin-bottom: 10px;
  }

  .pandoc-table th:not([align]) {
    text-align: left;
  }

  .pagedtable-footer {
    font-size: 15px;
  }

  d-byline .byline {
    grid-template-columns: 2fr 2fr;
  }

  d-byline .byline h3 {
    margin-block-start: 1.5em;
  }

  d-byline .byline .authors-affiliations h3 {
    margin-block-start: 0.5em;
  }

  .authors-affiliations .orcid-id {
    width: 16px;
    height:16px;
    margin-left: 4px;
    margin-right: 4px;
    vertical-align: middle;
    padding-bottom: 2px;
  }

  d-title .dt-tags {
    margin-top: 1em;
    grid-column: text;
  }

  .dt-tags .dt-tag {
    text-decoration: none;
    display: inline-block;
    color: rgba(0,0,0,0.6);
    padding: 0em 0.4em;
    margin-right: 0.5em;
    margin-bottom: 0.4em;
    font-size: 70%;
    border: 1px solid rgba(0,0,0,0.2);
    border-radius: 3px;
    text-transform: uppercase;
    font-weight: 500;
  }

  d-article table.gt_table td,
  d-article table.gt_table th {
    border-bottom: none;
  }

  .html-widget {
    margin-bottom: 2.0em;
  }

  .l-screen-inset {
    padding-right: 16px;
  }

  .l-screen .caption {
    margin-left: 10px;
  }

  .shaded {
    background: rgb(247, 247, 247);
    padding-top: 20px;
    padding-bottom: 20px;
    border-top: 1px solid rgba(0, 0, 0, 0.1);
    border-bottom: 1px solid rgba(0, 0, 0, 0.1);
  }

  .shaded .html-widget {
    margin-bottom: 0;
    border: 1px solid rgba(0, 0, 0, 0.1);
  }

  .shaded .shaded-content {
    background: white;
  }

  .text-output {
    margin-top: 0;
    line-height: 1.5em;
  }

  .hidden {
    display: none !important;
  }

  d-article {
    padding-top: 2.5rem;
    padding-bottom: 30px;
  }

  d-appendix {
    padding-top: 30px;
  }

  d-article>p>img {
    width: 100%;
  }

  d-article h2 {
    margin: 1rem 0 1.5rem 0;
  }

  d-article h3 {
    margin-top: 1.5rem;
  }

  d-article iframe {
    border: 1px solid rgba(0, 0, 0, 0.1);
    margin-bottom: 2.0em;
    width: 100%;
  }

  /* Tweak code blocks */

  d-article div.sourceCode code,
  d-article pre code {
    font-family: Consolas, Monaco, 'Andale Mono', 'Ubuntu Mono', monospace;
  }

  d-article pre,
  d-article div.sourceCode,
  d-article div.sourceCode pre {
    overflow: auto;
  }

  d-article div.sourceCode {
    background-color: white;
  }

  d-article div.sourceCode pre {
    padding-left: 10px;
    font-size: 12px;
    border-left: 2px solid rgba(0,0,0,0.1);
  }

  d-article pre {
    font-size: 12px;
    color: black;
    background: none;
    margin-top: 0;
    text-align: left;
    white-space: pre;
    word-spacing: normal;
    word-break: normal;
    word-wrap: normal;
    line-height: 1.5;

    -moz-tab-size: 4;
    -o-tab-size: 4;
    tab-size: 4;

    -webkit-hyphens: none;
    -moz-hyphens: none;
    -ms-hyphens: none;
    hyphens: none;
  }

  d-article pre a {
    border-bottom: none;
  }

  d-article pre a:hover {
    border-bottom: none;
    text-decoration: underline;
  }

  d-article details {
    grid-column: text;
    margin-bottom: 0.8em;
  }

  @media(min-width: 768px) {

  d-article pre,
  d-article div.sourceCode,
  d-article div.sourceCode pre {
    overflow: visible !important;
  }

  d-article div.sourceCode pre {
    padding-left: 18px;
    font-size: 14px;
  }

  d-article pre {
    font-size: 14px;
  }

  }

  figure img.external {
    background: white;
    border: 1px solid rgba(0, 0, 0, 0.1);
    box-shadow: 0 1px 8px rgba(0, 0, 0, 0.1);
    padding: 18px;
    box-sizing: border-box;
  }

  /* CSS for d-contents */

  .d-contents {
    grid-column: text;
    color: rgba(0,0,0,0.8);
    font-size: 0.9em;
    padding-bottom: 1em;
    margin-bottom: 1em;
    padding-bottom: 0.5em;
    margin-bottom: 1em;
    padding-left: 0.25em;
    justify-self: start;
  }

  @media(min-width: 1000px) {
    .d-contents.d-contents-float {
      height: 0;
      grid-column-start: 1;
      grid-column-end: 4;
      justify-self: center;
      padding-right: 3em;
      padding-left: 2em;
    }
  }

  .d-contents nav h3 {
    font-size: 18px;
    margin-top: 0;
    margin-bottom: 1em;
  }

  .d-contents li {
    list-style-type: none
  }

  .d-contents nav > ul {
    padding-left: 0;
  }

  .d-contents ul {
    padding-left: 1em
  }

  .d-contents nav ul li {
    margin-top: 0.6em;
    margin-bottom: 0.2em;
  }

  .d-contents nav a {
    font-size: 13px;
    border-bottom: none;
    text-decoration: none
    color: rgba(0, 0, 0, 0.8);
  }

  .d-contents nav a:hover {
    text-decoration: underline solid rgba(0, 0, 0, 0.6)
  }

  .d-contents nav > ul > li > a {
    font-weight: 600;
  }

  .d-contents nav > ul > li > ul {
    font-weight: inherit;
  }

  .d-contents nav > ul > li > ul > li {
    margin-top: 0.2em;
  }


  .d-contents nav ul {
    margin-top: 0;
    margin-bottom: 0.25em;
  }

  .d-article-with-toc h2:nth-child(2) {
    margin-top: 0;
  }


  /* Figure */

  .figure {
    position: relative;
    margin-bottom: 2.5em;
    margin-top: 1.5em;
  }

  .figure img {
    width: 100%;
  }

  .figure .caption {
    color: rgba(0, 0, 0, 0.6);
    font-size: 12px;
    line-height: 1.5em;
  }

  .figure img.external {
    background: white;
    border: 1px solid rgba(0, 0, 0, 0.1);
    box-shadow: 0 1px 8px rgba(0, 0, 0, 0.1);
    padding: 18px;
    box-sizing: border-box;
  }

  .figure .caption a {
    color: rgba(0, 0, 0, 0.6);
  }

  .figure .caption b,
  .figure .caption strong, {
    font-weight: 600;
    color: rgba(0, 0, 0, 1.0);
  }

  /* Citations */

  d-article .citation {
    color: inherit;
    cursor: inherit;
  }

  div.hanging-indent{
    margin-left: 1em; text-indent: -1em;
  }

  /* Citation hover box */

  .tippy-box[data-theme~=light-border] {
    background-color: rgba(250, 250, 250, 0.95);
  }

  .tippy-content > p {
    margin-bottom: 0;
    padding: 2px;
  }


  /* Tweak 1000px media break to show more text */

  @media(min-width: 1000px) {
    .base-grid,
    distill-header,
    d-title,
    d-abstract,
    d-article,
    d-appendix,
    distill-appendix,
    d-byline,
    d-footnote-list,
    d-citation-list,
    distill-footer {
      grid-template-columns: [screen-start] 1fr [page-start kicker-start] 80px [middle-start] 50px [text-start kicker-end] 65px 65px 65px 65px 65px 65px 65px 65px [text-end gutter-start] 65px [middle-end] 65px [page-end gutter-end] 1fr [screen-end];
      grid-column-gap: 16px;
    }

    .grid {
      grid-column-gap: 16px;
    }

    d-article {
      font-size: 1.06rem;
      line-height: 1.7em;
    }
    figure .caption, .figure .caption, figure figcaption {
      font-size: 13px;
    }
  }

  @media(min-width: 1180px) {
    .base-grid,
    distill-header,
    d-title,
    d-abstract,
    d-article,
    d-appendix,
    distill-appendix,
    d-byline,
    d-footnote-list,
    d-citation-list,
    distill-footer {
      grid-template-columns: [screen-start] 1fr [page-start kicker-start] 60px [middle-start] 60px [text-start kicker-end] 60px 60px 60px 60px 60px 60px 60px 60px [text-end gutter-start] 60px [middle-end] 60px [page-end gutter-end] 1fr [screen-end];
      grid-column-gap: 32px;
    }

    .grid {
      grid-column-gap: 32px;
    }
  }


  /* Get the citation styles for the appendix (not auto-injected on render since
     we do our own rendering of the citation appendix) */

  d-appendix .citation-appendix,
  .d-appendix .citation-appendix {
    font-size: 11px;
    line-height: 15px;
    border-left: 1px solid rgba(0, 0, 0, 0.1);
    padding-left: 18px;
    border: 1px solid rgba(0,0,0,0.1);
    background: rgba(0, 0, 0, 0.02);
    padding: 10px 18px;
    border-radius: 3px;
    color: rgba(150, 150, 150, 1);
    overflow: hidden;
    margin-top: -12px;
    white-space: pre-wrap;
    word-wrap: break-word;
  }

  /* Include appendix styles here so they can be overridden */

  d-appendix {
    contain: layout style;
    font-size: 0.8em;
    line-height: 1.7em;
    margin-top: 60px;
    margin-bottom: 0;
    border-top: 1px solid rgba(0, 0, 0, 0.1);
    color: rgba(0,0,0,0.5);
    padding-top: 60px;
    padding-bottom: 48px;
  }

  d-appendix h3 {
    grid-column: page-start / text-start;
    font-size: 15px;
    font-weight: 500;
    margin-top: 1em;
    margin-bottom: 0;
    color: rgba(0,0,0,0.65);
  }

  d-appendix h3 + * {
    margin-top: 1em;
  }

  d-appendix ol {
    padding: 0 0 0 15px;
  }

  @media (min-width: 768px) {
    d-appendix ol {
      padding: 0 0 0 30px;
      margin-left: -30px;
    }
  }

  d-appendix li {
    margin-bottom: 1em;
  }

  d-appendix a {
    color: rgba(0, 0, 0, 0.6);
  }

  d-appendix > * {
    grid-column: text;
  }

  d-appendix > d-footnote-list,
  d-appendix > d-citation-list,
  d-appendix > distill-appendix {
    grid-column: screen;
  }

  /* Include footnote styles here so they can be overridden */

  d-footnote-list {
    contain: layout style;
  }

  d-footnote-list > * {
    grid-column: text;
  }

  d-footnote-list a.footnote-backlink {
    color: rgba(0,0,0,0.3);
    padding-left: 0.5em;
  }



  /* Anchor.js */

  .anchorjs-link {
    /*transition: all .25s linear; */
    text-decoration: none;
    border-bottom: none;
  }
  *:hover > .anchorjs-link {
    margin-left: -1.125em !important;
    text-decoration: none;
    border-bottom: none;
  }

  /* Social footer */

  .social_footer {
    margin-top: 30px;
    margin-bottom: 0;
    color: rgba(0,0,0,0.67);
  }

  .disqus-comments {
    margin-right: 30px;
  }

  .disqus-comment-count {
    border-bottom: 1px solid rgba(0, 0, 0, 0.4);
    cursor: pointer;
  }

  #disqus_thread {
    margin-top: 30px;
  }

  .article-sharing a {
    border-bottom: none;
    margin-right: 8px;
  }

  .article-sharing a:hover {
    border-bottom: none;
  }

  .sidebar-section.subscribe {
    font-size: 12px;
    line-height: 1.6em;
  }

  .subscribe p {
    margin-bottom: 0.5em;
  }


  .article-footer .subscribe {
    font-size: 15px;
    margin-top: 45px;
  }


  .sidebar-section.custom {
    font-size: 12px;
    line-height: 1.6em;
  }

  .custom p {
    margin-bottom: 0.5em;
  }

  /* Styles for listing layout (hide title) */
  .layout-listing d-title, .layout-listing .d-title {
    display: none;
  }

  /* Styles for posts lists (not auto-injected) */


  .posts-with-sidebar {
    padding-left: 45px;
    padding-right: 45px;
  }

  .posts-list .description h2,
  .posts-list .description p {
    font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", Arial, sans-serif;
  }

  .posts-list .description h2 {
    font-weight: 700;
    border-bottom: none;
    padding-bottom: 0;
  }

  .posts-list h2.post-tag {
    border-bottom: 1px solid rgba(0, 0, 0, 0.2);
    padding-bottom: 12px;
  }
  .posts-list {
    margin-top: 60px;
    margin-bottom: 24px;
  }

  .posts-list .post-preview {
    text-decoration: none;
    overflow: hidden;
    display: block;
    border-bottom: 1px solid rgba(0, 0, 0, 0.1);
    padding: 24px 0;
  }

  .post-preview-last {
    border-bottom: none !important;
  }

  .posts-list .posts-list-caption {
    grid-column: screen;
    font-weight: 400;
  }

  .posts-list .post-preview h2 {
    margin: 0 0 6px 0;
    line-height: 1.2em;
    font-style: normal;
    font-size: 24px;
  }

  .posts-list .post-preview p {
    margin: 0 0 12px 0;
    line-height: 1.4em;
    font-size: 16px;
  }

  .posts-list .post-preview .thumbnail {
    box-sizing: border-box;
    margin-bottom: 24px;
    position: relative;
    max-width: 500px;
  }
  .posts-list .post-preview img {
    width: 100%;
    display: block;
  }

  .posts-list .metadata {
    font-size: 12px;
    line-height: 1.4em;
    margin-bottom: 18px;
  }

  .posts-list .metadata > * {
    display: inline-block;
  }

  .posts-list .metadata .publishedDate {
    margin-right: 2em;
  }

  .posts-list .metadata .dt-authors {
    display: block;
    margin-top: 0.3em;
    margin-right: 2em;
  }

  .posts-list .dt-tags {
    display: block;
    line-height: 1em;
  }

  .posts-list .dt-tags .dt-tag {
    display: inline-block;
    color: rgba(0,0,0,0.6);
    padding: 0.3em 0.4em;
    margin-right: 0.2em;
    margin-bottom: 0.4em;
    font-size: 60%;
    border: 1px solid rgba(0,0,0,0.2);
    border-radius: 3px;
    text-transform: uppercase;
    font-weight: 500;
  }

  .posts-list img {
    opacity: 1;
  }

  .posts-list img[data-src] {
    opacity: 0;
  }

  .posts-more {
    clear: both;
  }


  .posts-sidebar {
    font-size: 16px;
  }

  .posts-sidebar h3 {
    font-size: 16px;
    margin-top: 0;
    margin-bottom: 0.5em;
    font-weight: 400;
    text-transform: uppercase;
  }

  .sidebar-section {
    margin-bottom: 30px;
  }

  .categories ul {
    list-style-type: none;
    margin: 0;
    padding: 0;
  }

  .categories li {
    color: rgba(0, 0, 0, 0.8);
    margin-bottom: 0;
  }

  .categories li>a {
    border-bottom: none;
  }

  .categories li>a:hover {
    border-bottom: 1px solid rgba(0, 0, 0, 0.4);
  }

  .categories .active {
    font-weight: 600;
  }

  .categories .category-count {
    color: rgba(0, 0, 0, 0.4);
  }


  @media(min-width: 768px) {
    .posts-list .post-preview h2 {
      font-size: 26px;
    }
    .posts-list .post-preview .thumbnail {
      float: right;
      width: 30%;
      margin-bottom: 0;
    }
    .posts-list .post-preview .description {
      float: left;
      width: 45%;
    }
    .posts-list .post-preview .metadata {
      float: left;
      width: 20%;
      margin-top: 8px;
    }
    .posts-list .post-preview p {
      margin: 0 0 12px 0;
      line-height: 1.5em;
      font-size: 16px;
    }
    .posts-with-sidebar .posts-list {
      float: left;
      width: 75%;
    }
    .posts-with-sidebar .posts-sidebar {
      float: right;
      width: 20%;
      margin-top: 60px;
      padding-top: 24px;
      padding-bottom: 24px;
    }
  }


  /* Improve display for browsers without grid (IE/Edge <= 15) */

  .downlevel {
    line-height: 1.6em;
    font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", Arial, sans-serif;
    margin: 0;
  }

  .downlevel .d-title {
    padding-top: 6rem;
    padding-bottom: 1.5rem;
  }

  .downlevel .d-title h1 {
    font-size: 50px;
    font-weight: 700;
    line-height: 1.1em;
    margin: 0 0 0.5rem;
  }

  .downlevel .d-title p {
    font-weight: 300;
    font-size: 1.2rem;
    line-height: 1.55em;
    margin-top: 0;
  }

  .downlevel .d-byline {
    padding-top: 0.8em;
    padding-bottom: 0.8em;
    font-size: 0.8rem;
    line-height: 1.8em;
  }

  .downlevel .section-separator {
    border: none;
    border-top: 1px solid rgba(0, 0, 0, 0.1);
  }

  .downlevel .d-article {
    font-size: 1.06rem;
    line-height: 1.7em;
    padding-top: 1rem;
    padding-bottom: 2rem;
  }


  .downlevel .d-appendix {
    padding-left: 0;
    padding-right: 0;
    max-width: none;
    font-size: 0.8em;
    line-height: 1.7em;
    margin-bottom: 0;
    color: rgba(0,0,0,0.5);
    padding-top: 40px;
    padding-bottom: 48px;
  }

  .downlevel .footnotes ol {
    padding-left: 13px;
  }

  .downlevel .base-grid,
  .downlevel .distill-header,
  .downlevel .d-title,
  .downlevel .d-abstract,
  .downlevel .d-article,
  .downlevel .d-appendix,
  .downlevel .distill-appendix,
  .downlevel .d-byline,
  .downlevel .d-footnote-list,
  .downlevel .d-citation-list,
  .downlevel .distill-footer,
  .downlevel .appendix-bottom,
  .downlevel .posts-container {
    padding-left: 40px;
    padding-right: 40px;
  }

  @media(min-width: 768px) {
    .downlevel .base-grid,
    .downlevel .distill-header,
    .downlevel .d-title,
    .downlevel .d-abstract,
    .downlevel .d-article,
    .downlevel .d-appendix,
    .downlevel .distill-appendix,
    .downlevel .d-byline,
    .downlevel .d-footnote-list,
    .downlevel .d-citation-list,
    .downlevel .distill-footer,
    .downlevel .appendix-bottom,
    .downlevel .posts-container {
    padding-left: 150px;
    padding-right: 150px;
    max-width: 900px;
  }
  }

  .downlevel pre code {
    display: block;
    border-left: 2px solid rgba(0, 0, 0, .1);
    padding: 0 0 0 20px;
    font-size: 14px;
  }

  .downlevel code, .downlevel pre {
    color: black;
    background: none;
    font-family: Consolas, Monaco, 'Andale Mono', 'Ubuntu Mono', monospace;
    text-align: left;
    white-space: pre;
    word-spacing: normal;
    word-break: normal;
    word-wrap: normal;
    line-height: 1.5;

    -moz-tab-size: 4;
    -o-tab-size: 4;
    tab-size: 4;

    -webkit-hyphens: none;
    -moz-hyphens: none;
    -ms-hyphens: none;
    hyphens: none;
  }

  .downlevel .posts-list .post-preview {
    color: inherit;
  }



  </style>

  <script type="application/javascript">

  function is_downlevel_browser() {
    if (bowser.isUnsupportedBrowser({ msie: "12", msedge: "16"},
                                   window.navigator.userAgent)) {
      return true;
    } else {
      return window.load_distill_framework === undefined;
    }
  }

  // show body when load is complete
  function on_load_complete() {

    // add anchors
    if (window.anchors) {
      window.anchors.options.placement = 'left';
      window.anchors.add('d-article > h2, d-article > h3, d-article > h4, d-article > h5');
    }


    // set body to visible
    document.body.style.visibility = 'visible';

    // force redraw for leaflet widgets
    if (window.HTMLWidgets) {
      var maps = window.HTMLWidgets.findAll(".leaflet");
      $.each(maps, function(i, el) {
        var map = this.getMap();
        map.invalidateSize();
        map.eachLayer(function(layer) {
          if (layer instanceof L.TileLayer)
            layer.redraw();
        });
      });
    }

    // trigger 'shown' so htmlwidgets resize
    $('d-article').trigger('shown');
  }

  function init_distill() {

    init_common();

    // create front matter
    var front_matter = $('<d-front-matter></d-front-matter>');
    $('#distill-front-matter').wrap(front_matter);

    // create d-title
    $('.d-title').changeElementType('d-title');

    // create d-byline
    var byline = $('<d-byline></d-byline>');
    $('.d-byline').replaceWith(byline);

    // create d-article
    var article = $('<d-article></d-article>');
    $('.d-article').wrap(article).children().unwrap();

    // move posts container into article
    $('.posts-container').appendTo($('d-article'));

    // create d-appendix
    $('.d-appendix').changeElementType('d-appendix');

    // flag indicating that we have appendix items
    var appendix = $('.appendix-bottom').children('h3').length > 0;

    // replace footnotes with <d-footnote>
    $('.footnote-ref').each(function(i, val) {
      appendix = true;
      var href = $(this).attr('href');
      var id = href.replace('#', '');
      var fn = $('#' + id);
      var fn_p = $('#' + id + '>p');
      fn_p.find('.footnote-back').remove();
      var text = fn_p.html();
      var dtfn = $('<d-footnote></d-footnote>');
      dtfn.html(text);
      $(this).replaceWith(dtfn);
    });
    // remove footnotes
    $('.footnotes').remove();

    // move refs into #references-listing
    $('#references-listing').replaceWith($('#refs'));

    $('h1.appendix, h2.appendix').each(function(i, val) {
      $(this).changeElementType('h3');
    });
    $('h3.appendix').each(function(i, val) {
      var id = $(this).attr('id');
      $('.d-contents a[href="#' + id + '"]').parent().remove();
      appendix = true;
      $(this).nextUntil($('h1, h2, h3')).addBack().appendTo($('d-appendix'));
    });

    // show d-appendix if we have appendix content
    $("d-appendix").css('display', appendix ? 'grid' : 'none');

    // localize layout chunks to just output
    $('.layout-chunk').each(function(i, val) {

      // capture layout
      var layout = $(this).attr('data-layout');

      // apply layout to markdown level block elements
      var elements = $(this).children().not('details, div.sourceCode, pre, script');
      elements.each(function(i, el) {
        var layout_div = $('<div class="' + layout + '"></div>');
        if (layout_div.hasClass('shaded')) {
          var shaded_content = $('<div class="shaded-content"></div>');
          $(this).wrap(shaded_content);
          $(this).parent().wrap(layout_div);
        } else {
          $(this).wrap(layout_div);
        }
      });


      // unwrap the layout-chunk div
      $(this).children().unwrap();
    });

    // remove code block used to force  highlighting css
    $('.distill-force-highlighting-css').parent().remove();

    // remove empty line numbers inserted by pandoc when using a
    // custom syntax highlighting theme
    $('code.sourceCode a:empty').remove();

    // load distill framework
    load_distill_framework();

    // wait for window.distillRunlevel == 4 to do post processing
    function distill_post_process() {

      if (!window.distillRunlevel || window.distillRunlevel < 4)
        return;

      // hide author/affiliations entirely if we have no authors
      var front_matter = JSON.parse($("#distill-front-matter").html());
      var have_authors = front_matter.authors && front_matter.authors.length > 0;
      if (!have_authors)
        $('d-byline').addClass('hidden');

      // article with toc class
      $('.d-contents').parent().addClass('d-article-with-toc');

      // strip links that point to #
      $('.authors-affiliations').find('a[href="#"]').removeAttr('href');

      // add orcid ids
      $('.authors-affiliations').find('.author').each(function(i, el) {
        var orcid_id = front_matter.authors[i].orcidID;
        if (orcid_id) {
          var a = $('<a></a>');
          a.attr('href', 'https://orcid.org/' + orcid_id);
          var img = $('<img></img>');
          img.addClass('orcid-id');
          img.attr('alt', 'ORCID ID');
          img.attr('src','data:image/png;base64,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');
          a.append(img);
          $(this).append(a);
        }
      });

      // hide elements of author/affiliations grid that have no value
      function hide_byline_column(caption) {
        $('d-byline').find('h3:contains("' + caption + '")').parent().css('visibility', 'hidden');
      }

      // affiliations
      var have_affiliations = false;
      for (var i = 0; i<front_matter.authors.length; ++i) {
        var author = front_matter.authors[i];
        if (author.affiliation !== "&nbsp;") {
          have_affiliations = true;
          break;
        }
      }
      if (!have_affiliations)
        $('d-byline').find('h3:contains("Affiliations")').css('visibility', 'hidden');

      // published date
      if (!front_matter.publishedDate)
        hide_byline_column("Published");

      // document object identifier
      var doi = $('d-byline').find('h3:contains("DOI")');
      var doi_p = doi.next().empty();
      if (!front_matter.doi) {
        // if we have a citation and valid citationText then link to that
        if ($('#citation').length > 0 && front_matter.citationText) {
          doi.html('Citation');
          $('<a href="#citation"></a>')
            .text(front_matter.citationText)
            .appendTo(doi_p);
        } else {
          hide_byline_column("DOI");
        }
      } else {
        $('<a></a>')
           .attr('href', "https://doi.org/" + front_matter.doi)
           .html(front_matter.doi)
           .appendTo(doi_p);
      }

       // change plural form of authors/affiliations
      if (front_matter.authors.length === 1) {
        var grid = $('.authors-affiliations');
        grid.children('h3:contains("Authors")').text('Author');
        grid.children('h3:contains("Affiliations")').text('Affiliation');
      }

      // remove d-appendix and d-footnote-list local styles
      $('d-appendix > style:first-child').remove();
      $('d-footnote-list > style:first-child').remove();

      // move appendix-bottom entries to the bottom
      $('.appendix-bottom').appendTo('d-appendix').children().unwrap();
      $('.appendix-bottom').remove();

      // hoverable references
      $('span.citation[data-cites]').each(function() {
        if ($(this).children()[0].nodeName == "D-FOOTNOTE") {
          var fn = $(this).children()[0]
          $(this).html(fn.shadowRoot.querySelector("sup"))
          $(this).id = fn.id
          fn.remove()
        }
        var refs = $(this).attr('data-cites').split(" ");
        var refHtml = refs.map(function(ref) {
          return "<p>" + $('#ref-' + ref).html() + "</p>";
        }).join("\n");
        window.tippy(this, {
          allowHTML: true,
          content: refHtml,
          maxWidth: 500,
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        });
      });

      // clear polling timer
      clearInterval(tid);

      // show body now that everything is ready
      on_load_complete();
    }

    var tid = setInterval(distill_post_process, 50);
    distill_post_process();

  }

  function init_downlevel() {

    init_common();

     // insert hr after d-title
    $('.d-title').after($('<hr class="section-separator"/>'));

    // check if we have authors
    var front_matter = JSON.parse($("#distill-front-matter").html());
    var have_authors = front_matter.authors && front_matter.authors.length > 0;

    // manage byline/border
    if (!have_authors)
      $('.d-byline').remove();
    $('.d-byline').after($('<hr class="section-separator"/>'));
    $('.d-byline a').remove();

    // remove toc
    $('.d-contents').remove();

    // move appendix elements
    $('h1.appendix, h2.appendix').each(function(i, val) {
      $(this).changeElementType('h3');
    });
    $('h3.appendix').each(function(i, val) {
      $(this).nextUntil($('h1, h2, h3')).addBack().appendTo($('.d-appendix'));
    });


    // inject headers into references and footnotes
    var refs_header = $('<h3></h3>');
    refs_header.text('References');
    $('#refs').prepend(refs_header);

    var footnotes_header = $('<h3></h3');
    footnotes_header.text('Footnotes');
    $('.footnotes').children('hr').first().replaceWith(footnotes_header);

    // move appendix-bottom entries to the bottom
    $('.appendix-bottom').appendTo('.d-appendix').children().unwrap();
    $('.appendix-bottom').remove();

    // remove appendix if it's empty
    if ($('.d-appendix').children().length === 0)
      $('.d-appendix').remove();

    // prepend separator above appendix
    $('.d-appendix').before($('<hr class="section-separator" style="clear: both"/>'));

    // trim code
    $('pre>code').each(function(i, val) {
      $(this).html($.trim($(this).html()));
    });

    // move posts-container right before article
    $('.posts-container').insertBefore($('.d-article'));

    $('body').addClass('downlevel');

    on_load_complete();
  }


  function init_common() {

    // jquery plugin to change element types
    (function($) {
      $.fn.changeElementType = function(newType) {
        var attrs = {};

        $.each(this[0].attributes, function(idx, attr) {
          attrs[attr.nodeName] = attr.nodeValue;
        });

        this.replaceWith(function() {
          return $("<" + newType + "/>", attrs).append($(this).contents());
        });
      };
    })(jQuery);

    // prevent underline for linked images
    $('a > img').parent().css({'border-bottom' : 'none'});

    // mark non-body figures created by knitr chunks as 100% width
    $('.layout-chunk').each(function(i, val) {
      var figures = $(this).find('img, .html-widget');
      if ($(this).attr('data-layout') !== "l-body") {
        figures.css('width', '100%');
      } else {
        figures.css('max-width', '100%');
        figures.filter("[width]").each(function(i, val) {
          var fig = $(this);
          fig.css('width', fig.attr('width') + 'px');
        });

      }
    });

    // auto-append index.html to post-preview links in file: protocol
    // and in rstudio ide preview
    $('.post-preview').each(function(i, val) {
      if (window.location.protocol === "file:")
        $(this).attr('href', $(this).attr('href') + "index.html");
    });

    // get rid of index.html references in header
    if (window.location.protocol !== "file:") {
      $('.distill-site-header a[href]').each(function(i,val) {
        $(this).attr('href', $(this).attr('href').replace("index.html", "./"));
      });
    }

    // add class to pandoc style tables
    $('tr.header').parent('thead').parent('table').addClass('pandoc-table');
    $('.kable-table').children('table').addClass('pandoc-table');

    // add figcaption style to table captions
    $('caption').parent('table').addClass("figcaption");

    // initialize posts list
    if (window.init_posts_list)
      window.init_posts_list();

    // implmement disqus comment link
    $('.disqus-comment-count').click(function() {
      window.headroom_prevent_pin = true;
      $('#disqus_thread').toggleClass('hidden');
      if (!$('#disqus_thread').hasClass('hidden')) {
        var offset = $(this).offset();
        $(window).resize();
        $('html, body').animate({
          scrollTop: offset.top - 35
        });
      }
    });
  }

  document.addEventListener('DOMContentLoaded', function() {
    if (is_downlevel_browser())
      init_downlevel();
    else
      window.addEventListener('WebComponentsReady', init_distill);
  });

  </script>

  <style type="text/css">
  /* base variables */

  /* Edit the CSS properties in this file to create a custom
     Distill theme. Only edit values in the right column
     for each row; values shown are the CSS defaults.
     To return any property to the default,
     you may set its value to: unset
     All rows must end with a semi-colon.                      */

  /* Optional: embed custom fonts here with `@import`          */
  /* This must remain at the top of this file.                 */



  html {
    /*-- Main font sizes --*/
    --title-size:      50px;
    --body-size:       1.06rem;
    --code-size:       14px;
    --aside-size:      12px;
    --fig-cap-size:    13px;
    /*-- Main font colors --*/
    --title-color:     #000000;
    --header-color:    rgba(0, 0, 0, 0.8);
    --body-color:      rgba(0, 0, 0, 0.8);
    --aside-color:     rgba(0, 0, 0, 0.6);
    --fig-cap-color:   rgba(0, 0, 0, 0.6);
    /*-- Specify custom fonts ~~~ must be imported above   --*/
    --heading-font:    sans-serif;
    --mono-font:       monospace;
    --body-font:       sans-serif;
    --navbar-font:     sans-serif;  /* websites + blogs only */
  }

  /*-- ARTICLE METADATA --*/
  d-byline {
    --heading-size:    0.6rem;
    --heading-color:   rgba(0, 0, 0, 0.5);
    --body-size:       0.8rem;
    --body-color:      rgba(0, 0, 0, 0.8);
  }

  /*-- ARTICLE TABLE OF CONTENTS --*/
  .d-contents {
    --heading-size:    18px;
    --contents-size:   13px;
  }

  /*-- ARTICLE APPENDIX --*/
  d-appendix {
    --heading-size:    15px;
    --heading-color:   rgba(0, 0, 0, 0.65);
    --text-size:       0.8em;
    --text-color:      rgba(0, 0, 0, 0.5);
  }

  /*-- WEBSITE HEADER + FOOTER --*/
  /* These properties only apply to Distill sites and blogs  */

  .distill-site-header {
    --title-size:       18px;
    --text-color:       rgba(255, 255, 255, 0.8);
    --text-size:        15px;
    --hover-color:      white;
    --bkgd-color:       #0F2E3D;
  }

  .distill-site-footer {
    --text-color:       rgba(255, 255, 255, 0.8);
    --text-size:        15px;
    --hover-color:      white;
    --bkgd-color:       #0F2E3D;
  }

  /*-- Additional custom styles --*/
  /* Add any additional CSS rules below                      */
  </style>
  <style type="text/css">
  /* base variables */

  /* Edit the CSS properties in this file to create a custom
     Distill theme. Only edit values in the right column
     for each row; values shown are the CSS defaults.
     To return any property to the default,
     you may set its value to: unset
     All rows must end with a semi-colon.                      */

  /* Optional: embed custom fonts here with `@import`          */
  /* This must remain at the top of this file.                 */

  @import url('https://fonts.googleapis.com/css?family=Noto+Serif+KR');
  @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+KR:wght@300&display=swap');

  html {
    /*-- Main font sizes --*/
    --title-size:      50px;
    --body-size:       1.06rem;
    --code-size:       14px;
    --aside-size:      12px;
    --fig-cap-size:    13px;
    /*-- Main font colors --*/
    --title-color:     #000000;
    --header-color:    rgba(0, 0, 0, 0.8);
    --body-color:      rgba(0, 0, 0, 0.8);
    --aside-color:     rgba(0, 0, 0, 0.6);
    --fig-cap-color:   rgba(0, 0, 0, 0.6);
    /*-- Specify custom fonts ~~~ must be imported above   --*/
    --heading-font:    'Noto Sans Kr', sans-serif;
    --mono-font:       monospace;
    --body-font:       'Noto Serif KR', sans-serif;
    --navbar-font:     'Noto Sans Kr', sans-serif;  /* websites + blogs only */
  }

  /*-- ASIDE --*/

  d-article aside {
    width: 150%;
  }

  d-article aside li {
    line-height: 0.8rem
  }

  /*-- a concept explained in ASIDE --*/

  s {
    color: cadetblue;
    text-emphasis-style: dot;
    text-decoration-line: none;
    
  }

  /*-- ARTICLE METADATA --*/
  d-byline {
    --heading-size:    0.6rem;
    --heading-color:   rgba(0, 0, 0, 0.5);
    --body-size:       0.8rem;
    --body-color:      rgba(0, 0, 0, 0.8);
  }

  /*-- ARTICLE TABLE OF CONTENTS --*/

  .d-contents {
    --heading-size:    1.4rem;
    --contents-size:   0.8rem;
  }

  @media (min-width: 1000px) {
    .d-contents.d-contents-float {
        position: fixed;
        top: 20%;
        left: 2%;
        width: 16%;
    }
  }


  /*-- ARTICLE APPENDIX --*/
  d-appendix {
    --heading-size:    15px;
    --heading-color:   rgba(0, 0, 0, 0.65);
    --text-size:       0.8em;
    --text-color:      rgba(0, 0, 0, 0.5);
  }

  /*-- WEBSITE HEADER + FOOTER --*/
  /* These properties only apply to Distill sites and blogs  */

  .distill-site-header {
    --title-size:       18px;
    --text-color:       rgba(255, 255, 255, 0.8);
    --text-size:        15px;
    --hover-color:      white;
    --bkgd-color:       #0F2E3D;
  }

  .distill-site-footer {
    --text-color:       rgba(255, 255, 255, 0.8);
    --text-size:        15px;
    --hover-color:      white;
    --bkgd-color:       #0F2E3D;
  }

  /*-- Additional custom styles --*/
  /* Add any additional CSS rules below                      */

  d-article {
    contain: none !important;
  }

  d-contents .figcaption {
    line-height: 2rem;
  }

  figure {
    margin: 1rem auto;
    width: 75%;
  }


  figure figcaption,
  .figcaption p {
    border-bottom: 1px dotted black;
  }

  i.arrow {
    position: fixed;
    font-size: 5rem;
    top: 50%;
    color: rgb(25, 0, 125);
    opacity: 0.1;
  }

  i.arrow:hover {
    opacity: 0.5;
  }

  i.fa-arrow-alt-circle-left {
    left: 5%;
  }

  i.fa-arrow-alt-circle-right {
    right: 5%;
  }

  .title_box {
    position: relative; 
    background-color: white;
    width: 700px; 
  }

  .title_box li {
    list-style-type: none;
  }

  .title_border:before {
      content: "";
      background: linear-gradient(130deg,#ff7a18,#af002d 41.07%,#319197 76.05%);
      position: absolute;
      top: -5px;
      left: -5px;
      width: calc(100% + 10px);
      height: calc(100% + 10px);
      z-index: -1;
      border-radius: 12px;
  }

  .title_inside {
    padding: 20px;
  }

  d-article a {
    border-bottom: none;
    opacity: 0.6;
  }
  d-article a:hover {
    opacity: 1;
    color: color: rgb(25, 0, 125);
    border-bottom: none;
  }

  .d-contents nav a {
    text-decoration: none;
    border-bottom: none;
    opacity: 0.6;
  }
  .d-contents nav a:hover {
    text-decoration: none;
    border-bottom: none;
    opacity: 1;
  }

  /* Table decoration  */
  table td {
    vertical-align: top;
  }</style>
  <style type="text/css">
  /* base style */

  /* FONT FAMILIES */

  :root {
    --heading-default: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", Arial, sans-serif;
    --mono-default: Consolas, Monaco, 'Andale Mono', 'Ubuntu Mono', monospace;
    --body-default: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", Arial, sans-serif;
  }

  body,
  .posts-list .post-preview p,
  .posts-list .description p {
    font-family: var(--body-font), var(--body-default);
  }

  h1, h2, h3, h4, h5, h6,
  .posts-list .post-preview h2,
  .posts-list .description h2 {
    font-family: var(--heading-font), var(--heading-default);
  }

  d-article div.sourceCode code,
  d-article pre code {
    font-family: var(--mono-font), var(--mono-default);
  }


  /*-- TITLE --*/
  d-title h1,
  .posts-list > h1 {
    color: var(--title-color, black);
  }

  d-title h1 {
    font-size: var(--title-size, 50px);
  }

  /*-- HEADERS --*/
  d-article h1,
  d-article h2,
  d-article h3,
  d-article h4,
  d-article h5,
  d-article h6 {
    color: var(--header-color, rgba(0, 0, 0, 0.8));
  }

  /*-- BODY --*/
  d-article > p,  /* only text inside of <p> tags */
  d-article > ul, /* lists */
  d-article > ol {
    color: var(--body-color, rgba(0, 0, 0, 0.8));
    font-size: var(--body-size, 1.06rem);
  }


  /*-- CODE --*/
  d-article div.sourceCode code,
  d-article pre code {
    font-size: var(--code-size, 14px);
  }

  /*-- ASIDE --*/
  d-article aside {
    font-size: var(--aside-size, 12px);
    color: var(--aside-color, rgba(0, 0, 0, 0.6));
  }

  /*-- FIGURE CAPTIONS --*/
  figure .caption,
  figure figcaption,
  .figure .caption {
    font-size: var(--fig-cap-size, 13px);
    color: var(--fig-cap-color, rgba(0, 0, 0, 0.6));
  }

  /*-- METADATA --*/
  d-byline h3 {
    font-size: var(--heading-size, 0.6rem);
    color: var(--heading-color, rgba(0, 0, 0, 0.5));
  }

  d-byline {
    font-size: var(--body-size, 0.8rem);
    color: var(--body-color, rgba(0, 0, 0, 0.8));
  }

  d-byline a,
  d-article d-byline a {
    color: var(--body-color, rgba(0, 0, 0, 0.8));
  }

  /*-- TABLE OF CONTENTS --*/
  .d-contents nav h3 {
    font-size: var(--heading-size, 18px);
  }

  .d-contents nav a {
    font-size: var(--contents-size, 13px);
  }

  /*-- APPENDIX --*/
  d-appendix h3 {
    font-size: var(--heading-size, 15px);
    color: var(--heading-color, rgba(0, 0, 0, 0.65));
  }

  d-appendix {
    font-size: var(--text-size, 0.8em);
    color: var(--text-color, rgba(0, 0, 0, 0.5));
  }

  d-appendix d-footnote-list a.footnote-backlink {
    color: var(--text-color, rgba(0, 0, 0, 0.5));
  }

  /*-- WEBSITE HEADER + FOOTER --*/
  .distill-site-header .title {
    font-size: var(--title-size, 18px);
    font-family: var(--navbar-font), var(--heading-default);
  }

  .distill-site-header a,
  .nav-dropdown .nav-dropbtn {
    font-family: var(--navbar-font), var(--heading-default);
  }

  .nav-dropdown .nav-dropbtn {
    color: var(--text-color, rgba(255, 255, 255, 0.8));
    font-size: var(--text-size, 15px);
  }

  .distill-site-header a:hover,
  .nav-dropdown:hover .nav-dropbtn {
    color: var(--hover-color, white);
  }

  .distill-site-header {
    font-size: var(--text-size, 15px);
    color: var(--text-color, rgba(255, 255, 255, 0.8));
    background-color: var(--bkgd-color, #0F2E3D);
  }

  .distill-site-footer {
    font-size: var(--text-size, 15px);
    color: var(--text-color, rgba(255, 255, 255, 0.8));
    background-color: var(--bkgd-color, #0F2E3D);
  }

  .distill-site-footer a:hover {
    color: var(--hover-color, white);
  }</style>
  <!--/radix_placeholder_distill-->
  <script src="site_libs/header-attrs-2.13/header-attrs.js"></script>
  <script src="site_libs/popper-2.6.0/popper.min.js"></script>
  <link href="site_libs/tippy-6.2.7/tippy.css" rel="stylesheet" />
  <link href="site_libs/tippy-6.2.7/tippy-light-border.css" rel="stylesheet" />
  <script src="site_libs/tippy-6.2.7/tippy.umd.min.js"></script>
  <script src="site_libs/anchor-4.2.2/anchor.min.js"></script>
  <script src="site_libs/bowser-1.9.3/bowser.min.js"></script>
  <script src="site_libs/webcomponents-2.0.0/webcomponents.js"></script>
  <script src="site_libs/distill-2.2.21/template.v2.js"></script>
  <!--radix_placeholder_site_in_header-->
  <!--/radix_placeholder_site_in_header-->


</head>

<body>

<!--radix_placeholder_front_matter-->

<script id="distill-front-matter" type="text/json">
{"title":"11장 4절: 클로자핀 투여 전략","description":"Treatment Strategies using Clozapine","authors":[]}
</script>

<!--/radix_placeholder_front_matter-->
<!--radix_placeholder_navigation_before_body-->
<header class="header header--fixed" role="banner">
<nav class="distill-site-nav distill-site-header">
<div class="nav-left">
<a class="logo">
<img src="images/logo2.png" alt="Logo"/>
</a>
<a href="index.html" class="title">KYS study group</a>
<input id="distill-search" class="nav-search hidden" type="text" placeholder="Search..."/>
</div>
<div class="nav-right">
<a href="index.html">Front Matter</a>
<div class="nav-dropdown">
<button class="nav-dropbtn">
Contents
 
<span class="down-arrow">&#x25BE;</span>
</button>
<div class="nav-dropdown-content">
<a href="frontmatter-01.html">1. Understanding of Schizophrenia</a>
<a href="frontmatter-02.html">2. Biological Basis of Schizophrenia</a>
<a href="frontmatter-03.html">3. History of Antipsychotic Treatment</a>
<a href="frontmatter-04.html">4. Basic Concetps in Antipsychotic Treatment</a>
</div>
</div>
<a href="about.html">Authors</a>
<a href="https://github.com/AnselmJeong/distill">
<i class="fab fa-github" aria-hidden="true"></i>
</a>
<a href="javascript:void(0);" class="nav-toggle">&#9776;</a>
</div>
</nav>
</header>
<!--/radix_placeholder_navigation_before_body-->
<!--radix_placeholder_site_before_body-->
<!--/radix_placeholder_site_before_body-->

<div class="d-title">
<h1>11장 4절: 클로자핀 투여 전략</h1>
<!--radix_placeholder_categories-->
<!--/radix_placeholder_categories-->
<p>Treatment Strategies using Clozapine</p>
</div>


<div class="d-article">
<div class="d-contents d-contents-float">
<nav class="l-text toc figcaption" id="TOC">
<h3>Contents</h3>
<ul>
<li><a href="#치료저항성-조현병에서-클로자핀의-효과">4-1. 치료저항성
조현병에서 클로자핀의 효과</a>
<ul>
<li><a href="#클로자핀-투여가-지연되었을-때의-문제점">4-1-1. 클로자핀
투여가 지연되었을 때의 문제점</a></li>
<li><a href="#양성-증상-이외의-치료-효과">4-1-2. 양성 증상 이외의 치료
효과</a></li>
</ul></li>
<li><a href="#클로자핀-저항성">4-2. 클로자핀 저항성</a>
<ul>
<li><a href="#임상적-특징">4-2-1. 임상적 특징</a></li>
<li><a href="#클로자핀-저항성-환자의-치료-전략">4-2-2. 클로자핀 저항성
환자의 치료 전략</a></li>
</ul></li>
</ul>
</nav>
</div>
<p><a href="article-11-03.html"><i class="arrow far fa-arrow-alt-circle-left"></i></a></p>
<p><a href="article-11-04.html"><i class="arrow far fa-arrow-alt-circle-right"></i></a></p>
<h2 id="치료저항성-조현병에서-클로자핀의-효과">4-1. 치료저항성
조현병에서 클로자핀의 효과</h2>
<p>치료저항성 조현병에 있어 클로자핀 투여가 모든 문제의 해답일 수는
없다. 그러나 그만한 대안도 없는 것이 사실이다. 보수적 의사들은 클로자핀
투여를 최대한 마지막 수단으로 남겨놓으려 하며, 보다 급진적인 의사들은
일찌감치 시도하고자 한다. 전자의 경우에도 이유가 없는 것이 아니다.
클로자핀은 무과립구증이라는 치명적인 부작용 외에도 다양한 부작용을 갖고
있으며, 이는 환자의 신체적 건강 뿐 아니라 삶의 질을 위협할 수 있다.
게다가 치료 초기부터 최종 수단을 사용해버리면, 이마저도 효과가 없을 때
속수무책의 궁지에 몰리게 된다. 의사들의 경험 상 발병 초기에는 비교적
약물에 잘 반응한다는 것을 알고 있다. 따라서 발병한 지 수년 이내의
환자에게는 최대한 다양한 약을 시도해보면서, 클로자핀이 아니고도 환자에게
맞는 약을 찾고자 노력한다. 보수적 의사들에게 클로자핀은 그 이후에나
시도해 보는 약물이다.</p>
<p>반면 급진적인 의사들 역시 확고한 근거를 갖고 있다. 한 연구에 따르면
클로자핀을 사용하기 전에 10.1%–36.2% 환자에서 허가된 최고 용량 이상의
항정신병 약물이 사용되었고, 15.9%-60.5%에서는 다약제 처방이
이루어졌다.[<span class="citation" data-cites="RN173">McEvoy, Hogarty,
and Steingard (<a href="#ref-RN173"
role="doc-biblioref">1991</a>)</span>]<span class="citation"
data-cites="RN172">(<a href="#ref-RN172" role="doc-biblioref">Wiersma et
al. 1998</a>)</span> 그러나 고용량에 반응한 환자는 15.5% 정도, 몇 번
약물을 교체한 후에 반응한 환자는 16.7% 정도였으며, 2가지 이상의 항정신병
약물을 병용한 경우에도 반응률은 고작 20%를 좀 넘는 수준이었다.[<span
class="citation" data-cites="RN175">Kolakowska et al. (<a
href="#ref-RN175" role="doc-biblioref">1985</a>)</span>]<span
class="citation" data-cites="RN123">(<a href="#ref-RN123"
role="doc-biblioref">Agid et al. 2011</a>)</span> 즉 치료저항성이 드러난
환자에게 클로자핀이 아닌 다른 방법을 시도하는 것은 불필요하게 치료
시기만 늦추는 것에 지나지 않았다.<span class="citation"
data-cites="RN75">(<a href="#ref-RN75" role="doc-biblioref">J. M. Kane
et al. 2019</a>)</span> 이렇게 요행을 바라며 질질 끄는 것은, 클로자핀
사용에 대한 환자 및 치료진의 불안감을 해결하지 못했기 때문인지도
모른다.</p>
<p>클로자핀이 치료저항성 환자에게 우수한 효과를 나타내는 것은 의문의
여지가 없다. 결정적인 Kane의 연구<span class="citation"
data-cites="RN176">(<a href="#ref-RN176" role="doc-biblioref">J. Kane et
al. 1988</a>)</span> 이외에도 클로자핀의 우수성을 입증하는 연구는 셀 수
없이 많다. 물론 타 약물에 대한 우월성이 입증되지 못한 연구도 있지만,
이는 클로자핀의 용량을 과감하게 올리지 못했기 때문인 경우가 많다.<span
class="citation" data-cites="RN352">(<a href="#ref-RN352"
role="doc-biblioref">Samara et al. 2016</a>)</span> 치료반응을 보이는
클로자핀의 적절 혈중농도는 350~420 ng/ml 정도이나 드물지 않게 500 ng/ml
이상에서 반응이 나타나는 경우가 있으며, <s>천장효과</s>가 나타나는 것은
600-838 ng/ml 이상일 때이다.[<span class="citation"
data-cites="RN203">Remington et al. (<a href="#ref-RN203"
role="doc-biblioref">2013</a>)</span>]<span class="citation"
data-cites="RN34">(<a href="#ref-RN34" role="doc-biblioref">Faden and
Citrome 2019</a>)</span> 이 정도 혈중농도에 도달하려면 꽤 높은 용량을
써야 하는데, 실제 임상에서는 다양한 부작용 특히 경련발작의 위험때문에
충분히 용량을 높이지 못하는 경우가 많다.</p>
<aside>
<p><strong>천장효과(ceiling effect)</strong>: 약물 용량 혹은 농도와
효능의 관계는 어느 정도까지는 비례관계를 보이지만, 농도가 일정 수준
이상을 넘게되면 더 이상 효능이 증가하지 않는 경우를 가리킨다. 천정용량은
최대 효능이 나타나는 최소 농도 라고도 이야기할 수 있다.</p>
</aside>
<p>실제 사용에서의 어려운 점에도 불구하고, 클로자핀은 단기적으로 뿐
아니라 장기적으로도 정형/비정형 약물을 통털어서 가장 효과적이다.<span
class="citation" data-cites="RN170">(<a href="#ref-RN170"
role="doc-biblioref">Dan Siskind et al. 2016</a>)</span> 그 우수성은
치료저항성 환자에만 국한되는 것이 아니기 때문에, 무과립구증의 위험이
아니라면 초발 환자에서도 권해질 정도이다.<span class="citation"
data-cites="RN203">(<a href="#ref-RN203" role="doc-biblioref">Remington
et al. 2013</a>)</span> 현재 많은 치료 가이드라인에서 클로자핀은 두차례
이상의 약물 치료 실패 후에 고려될 수 있으며, 자살위험이 높을 때 혹은
지속적인 공격성이나 폭력적인 행동을 보일 때는 좀더 일찍 사용될 수 있다.
그러나 이러한 지침은 잘 지켜지지 않고 있으며, 클로자핀 사용 빈도 역시
일정 수준 이상으로는 그다지 높아지지 않고 있다.[<span class="citation"
data-cites="Warnez2014">Warnez and Alessi-Severini (<a
href="#ref-Warnez2014" role="doc-biblioref">2014</a>)</span>]<span
class="citation" data-cites="Roberts2018">(<a href="#ref-Roberts2018"
role="doc-biblioref">Roberts et al. 2018</a>)</span> 의사들의 부담감을
넘어서기에는 위험해 보이는 약물이긴 하지만, 좀더 적극적인 사용이
요청되는 바이다.<span class="citation" data-cites="Stahl2014">(<a
href="#ref-Stahl2014" role="doc-biblioref">Stahl 2014</a>)</span></p>
<h3 id="클로자핀-투여가-지연되었을-때의-문제점">4-1-1. 클로자핀 투여가
지연되었을 때의 문제점</h3>
<p>클로자핀을 보다 적극적으로 투여할 것을 지지하는 연구자들은,
클로자핀에 대한 반응에도 골든 타임이 있다고 주장한다. 정신병의 비치료
기간(duration of untreated psychosis)이 평생의 예후를 결정하는데 중요한
역할을 하는 것처럼, 치료저항성 조현병에서 클로자핀을 언제 시작했느냐가
이후 예후를 결정지을 수 있다고 한다. 재발이 반복될 수록 신경퇴행의
정도가 심화되어 치료 반응이 떨어지는 것처럼, 현저한 증상이 지속되는
기간이 길면 길수록 클로자핀 조차 듣지 않는 지경에 이르게 되기
때문이다.</p>
<p>일부 연구자들은 치료저항성이 불거진 지 3년 이내에 클로자핀이 투여되지
않으면 유일한 기회를 놓치는 셈이라고 경고한다.[<span class="citation"
data-cites="RN189">Birchwood, Todd, and Jackson (<a href="#ref-RN189"
role="doc-biblioref">1998</a>)</span>]<span class="citation"
data-cites="RN190">(<a href="#ref-RN190" role="doc-biblioref">Garety and
Jolley 2000</a>)</span><span class="citation" data-cites="RN191">(<a
href="#ref-RN191" role="doc-biblioref">Üçok et al. 2015</a>)</span>
클로자핀의 시작을 늦추는 것 자체가 클로자핀에 대한 반응성을 낮춘다는
과감한 주장이다. Yoshimura 등<span class="citation"
data-cites="RN192">(<a href="#ref-RN192" role="doc-biblioref">Yoshimura
et al. 2017</a>)</span>은 두 가지 이상의 항정신병 약물 치료에 실패한
시점을 치료저항성의 진단시점으로 잡고, 이후 얼마나 빨리 클로자핀이
투여되었느냐에 따라 클로자핀 치료에 대한 반응률을 비교해보았다. 그 결과
2.8년이 지나기 전에 클로자핀이 투여되었던 경우의 반응률이 81.6% 였음에
비해, 더 지연되어 투여되었던 경우에는 30.8%에 지나지 않았다. Üçok
등<span class="citation" data-cites="RN191">(<a href="#ref-RN191"
role="doc-biblioref">Üçok et al. 2015</a>)</span>도 유사한 결과를
얻었는데, 클로자핀 치료의 성공 여부를 결정짓는 것은 클로자핀이 투여될
때까지의 지연 시간과 최대용량이었다. 이러한 결과들을 종합하면, 2~3개의
항정신병 약물에 의한 치료에 실패한 경우, 적어도 3년이 지나기 전에
클로자핀을 투여하는 것이, 클로자핀 저항성을 최대한 예방하는 방법이라 할
수 있다. 일단 클로자핀 저항성으로 판정된다면, 이들에게 행해볼 수 있는
치료 전략은 매우 제한되기 때문이다.[<span class="citation"
data-cites="RN193">Muscatello et al. (<a href="#ref-RN193"
role="doc-biblioref">2014</a>)</span>]<span class="citation"
data-cites="RN194">(<a href="#ref-RN194" role="doc-biblioref">Miyamoto,
Jarskog, and Fleischhacker 2015</a>)</span></p>
<h3 id="양성-증상-이외의-치료-효과">4-1-2. 양성 증상 이외의 치료
효과</h3>
<p>현저한 양성 증상과 함께 공격성을 보일 때, 또는 감정 기복이 심해
우울에 쉽게 빠지거나 충동적으로 자해나 자살 사고를 보일 때, 전통적으로는
항정신병 약물에 리튬이나 항경련제를 병용투여해 왔다. 그러나 클로자핀은
단일요법으로 사용해도 공격행동을 줄일 뿐더러 자살율을 감소시킨다.<span
class="citation" data-cites="RN178">(<a href="#ref-RN178"
role="doc-biblioref">Hennen and Baldessarini 2005</a>)</span> 2년에 걸친
무작위 임상시험이었던 International Suicide Prevention Trial
(InterSePT)에서도 클로자핀은 올란자핀에 비해 유의한 자살 방지 효과를
보였다.<span class="citation" data-cites="RN177">(<a href="#ref-RN177"
role="doc-biblioref">Alphs et al. 2004</a>)</span> 이 결과에 근거하여
미국 식품의약품 안전처(FDA)는 조현병에서의 자살 위험을 클로자핀의 적응증
중 하나로 인정하였다. 덴마아크의 전국적 약물처방기록을 보면, 클로자핀
이외의 항정신병 약물을 사용한 환자는 클로자핀 사용 환자에 비해 1.36배
높은 자해 위험성을 보이고, 두 배에 가까운 사망률을 보였다.<span
class="citation" data-cites="RN205">(<a href="#ref-RN205"
role="doc-biblioref">Wimberley et al. 2017</a>)</span> 또한 클로자핀은
양성 효과에 미치는 영향과는 독립적으로 지속적인 공격성과 충동적 과격함을
감소시킬 수 있으며, 공격성에 대한 효과는 특히 치료저항성 환자에서
두드러진다.<span class="citation" data-cites="RN182">(<a
href="#ref-RN182" role="doc-biblioref">Frogley et al.
2012</a>)</span></p>
<h2 id="클로자핀-저항성">4-2. 클로자핀 저항성</h2>
<p>클로자핀이 아무리 효과적인 대안이라 할 지라도, 40~70%의 환자는 여전히
효과가 만족스럽지 못하다.<span class="citation" data-cites="RN75">(<a
href="#ref-RN75" role="doc-biblioref">J. M. Kane et al. 2019</a>)</span>
클로자핀에 대한 반응여부는 타 항정신병 약물보다는 좀 더 신중을 기해서,
적어도 혈중 농도 350 ng/ml 이상을 유지한 채 8주 이상 지난 후에야
평가한다. 이 기간 중 BPRS-18 혹은 PANSS 점수가 20% 이상 감소되지
않는다면 클로자핀 저항성으로 판정한다. 클로자핀 사용 후에도 앞서 언급한
케인의 치료저항성 기준(<a href="article-11-01.html#kane-resistance">11장
1-3-1 참조</a>) 을 만족하면 초 저항성(ultra-resistance)이라 부르기도
한다.<span class="citation" data-cites="RN266">(<a href="#ref-RN266"
role="doc-biblioref">Mouaffak et al. 2006</a>)</span></p>
<p>클로자핀 치료에 저항적인 환자는 부차적 이유로 해서 클로자핀을 충분히
투여할 수 없었던 경우와, 충분히 용량을 높였음에도 불구하고 치료가 되지
않는 경우로 나눌 수 있다. 무과립구증을 제외하고, 클로자핀을 충분히 쓸 수
없는 가장 흔한 원인은 경련발작이다. 경련의 유병률은 적게는 5%에서 많게는
20% 정도까지 보고되며, 경련에 이르지 않는 뇌파 이상의 비율은 그보다 훨씬
더 많다.<span class="citation" data-cites="Williams2015">(<a
href="#ref-Williams2015" role="doc-biblioref">Williams and Park
2014</a>)</span>) 문제는 경련의 위험이 용량이나 혈중 농도와 직접적으로
비례한다는 것이다. 일일 300mg 이하에서는 0.6~2%, 300~600mg 사이에서는
1.8~4%이지만, 600mg를 넘어서면 5~14%에서 경련발작을 일으킨다.<span
class="citation" data-cites="Kikuchi2014">(<a href="#ref-Kikuchi2014"
role="doc-biblioref">Kikuchi et al. 2014</a>)</span> 한번 경련을
일으키면 다시 일으킬 가능성이 높기 때문에, 자연히 용량을 높이는 것을
주저할 수 밖에 없다. 이 외에도 침흘림, 진정 작용, 기립성 저혈압 등이
용량 의존적이라고 여겨진다. 클로자핀의 허용 용량은 900mg이며, 최대용량에
근접하는 용량은 적어도 400mg이다. 그러나 적지 않은 의사들은 400mg의
용량도 환자의 삶의 질을 망가뜨린다고 생각한다.<span class="citation"
data-cites="Yamin2010">(<a href="#ref-Yamin2010"
role="doc-biblioref">Yamin and Vaddadi 2010</a>)</span></p>
<p>클로자핀 저항성에 대해 다양한 치료 전략이 시도되었다.<span
class="citation" data-cites="RN194">(<a href="#ref-RN194"
role="doc-biblioref">Miyamoto, Jarskog, and Fleischhacker
2015</a>)</span> 클로자핀에 반응이 만족스럽지 못하더라도, 클로자핀을
포기하지 않는 것이 모든 치료 전략의 공통점이다. 대신 다양한 약물을
병용하게 되는데, 아미설프라이드, 설피라이드, 리스페리돈 및 아리피프라졸
등이 비교적 많은 데이터를 갖고 있다.[<span class="citation"
data-cites="RN274">Josiassen et al. (<a href="#ref-RN274"
role="doc-biblioref">2005</a>)</span>]<span class="citation"
data-cites="RN275">(<a href="#ref-RN275" role="doc-biblioref">Honer et
al. 2006</a>)</span>[<span class="citation" data-cites="RN272">Mitsonis
et al. (<a href="#ref-RN272" role="doc-biblioref">2007</a>)</span>]<span
class="citation" data-cites="RN276">(<a href="#ref-RN276"
role="doc-biblioref">Assion et al. 2008</a>)</span><span
class="citation" data-cites="RN271">(<a href="#ref-RN271"
role="doc-biblioref">Chang et al. 2008</a>)</span> 병용 투여 후 오히려
증상이 악화될 수도 있기 때문에, 클로자핀 투여 개시 후 적어도 3-6개월간
반응을 점검한 뒤에 고려하며, 병용 투여 후 10주가 지나도 별다른 개선이
없다면 병용 약물은 중단한다.[<span class="citation"
data-cites="RN269">Chan et al. (<a href="#ref-RN269"
role="doc-biblioref">2005</a>)</span>]<span class="citation"
data-cites="RN277">(<a href="#ref-RN277" role="doc-biblioref">Paton,
Whittington, and Barnes 2007</a>)</span> 항정신병 약물 이외의 약물로는
특히 라모트리진이 도움이 된다는 보고가 있다.[<span class="citation"
data-cites="RN278">Goff (<a href="#ref-RN278"
role="doc-biblioref">2009</a>)</span>]<span class="citation"
data-cites="Tiihonen2009">(<a href="#ref-Tiihonen2009"
role="doc-biblioref">Tiihonen, Wahlbeck, and Kiviniemi 2009</a>)</span>
만약 병용 투여 전략이 실패하면 전기경련 치료를 시도하게 된다.</p>
<h3 id="임상적-특징">4-2-1. 임상적 특징</h3>
<p>클로자핀을 투여해도 줄어들지 않는 양성 증상이 클로자핀 저항성의
핵심이다.[<span class="citation" data-cites="RN266">Mouaffak et al. (<a
href="#ref-RN266" role="doc-biblioref">2006</a>)</span>]<span
class="citation" data-cites="RN280">(<a href="#ref-RN280"
role="doc-biblioref">Lee et al. 2015</a>)</span> 클로자핀을 투여해도
음성/인지 증상이 좋아지지 않는다고 해서 클로자핀 저항성이라 이름붙이진
않는다. 클로자핀 저항성 환자라고 해서, 일반적 항정신병 약물 저항성
환자와 비교했을 때 인지기능 저하정도의 차이는 없었다.<span
class="citation" data-cites="RN281">(<a href="#ref-RN281"
role="doc-biblioref">Anderson et al. 2015</a>)</span></p>
<p>클로자핀 저항성 환자는 전체 조현병 환자의 12~20%를 차지한다.<span
class="citation" data-cites="RN168">(<a href="#ref-RN168"
role="doc-biblioref">D. Siskind, Siskind, and Kisely 2017</a>)</span>
대부분은 발병 당시부터 치료저항성을 보인다.[<span class="citation"
data-cites="RN123">Agid et al. (<a href="#ref-RN123"
role="doc-biblioref">2011</a>)</span>]<span class="citation"
data-cites="RN122">(<a href="#ref-RN122" role="doc-biblioref">Lally et
al. 2016</a>)</span><span class="citation" data-cites="RN62">(<a
href="#ref-RN62" role="doc-biblioref">Demjaha et al. 2017</a>)</span>
치료저항성 환자군에게 클로자핀 투여를 미루면 미룰 수록 클로자핀 저항성의
위험이 커지는 것으로 보인다.[<span class="citation"
data-cites="RN191">Üçok et al. (<a href="#ref-RN191"
role="doc-biblioref">2015</a>)</span>]<span class="citation"
data-cites="RN200">(<a href="#ref-RN200" role="doc-biblioref">Yada,
Yoshimura, and Kishi 2015</a>)</span><span class="citation"
data-cites="RN192">(<a href="#ref-RN192" role="doc-biblioref">Yoshimura
et al. 2017</a>)</span></p>
<h3 id="클로자핀-저항성-환자의-치료-전략">4-2-2. 클로자핀 저항성 환자의
치료 전략</h3>
<p>클로자핀에 듣지 않는 환자를 다른 항정신병 약물로 교체한다는 것은
출발점부터 불리한 위치에 서 있다. 애초에 다른 약물에 듣지 않아서
클로자핀으로 넘어왔을 것이기 때문이다. 그러나 너무나 적극적인 의사가
지나치게 서둘러 클로자핀을 투여했던 경우, 혹은 효과는 있었지만 내약성
때문에 클로자핀을 투여할 수 없게 된 경우에는 타 약물로의 교체가 효과적일
수 있다. 이런 경우 전통적으로 클로자핀과 분자구조가 가장 유사한
올란자핀으로 전환하는 것이 고려되었으며 긍정적인 성과를 내기도
하였다.<span class="citation" data-cites="Dossenbach2000">(<a
href="#ref-Dossenbach2000" role="doc-biblioref">Dossenbach et al.
2000</a>)</span> 증례 보고에 지나지 않지만, 클로자핀에 의한 장폐색
때문에 클로자핀을 끊을 수 밖에 없었던 환자에게 아리피프라졸을 투여한
이후 오히려 그전보다 증상이 좋아졌다는 보고가 있다.<span
class="citation" data-cites="Feeley2017">(<a href="#ref-Feeley2017"
role="doc-biblioref">Feeley, Arnaout, and Yoon 2017</a>)</span> 또 다른
연구에서는 치료저항성 때문에 클로자핀을 사용하던 환자를 장기지속형
주사제로 교체했더니 임상상이 악화되지 않으면서 대사증후군 지표가 모두
좋아졌다고 하였다.<span class="citation"
data-cites="Martínez-Andrés2020">(<a href="#ref-Martínez-Andrés2020"
role="doc-biblioref">Martínez-Andrés and García-Carmona 2020</a>)</span>
그러나 이 연구는 일반적 치료저항성 환자를 대상으로 했지, 클로자핀 저항성
환자를 대상으로 한 것은 아니었다. 결론적으로 말하면, 클로자핀 저항성
환자를 다른 항정신병 약물로 교체해서 긍정적 결과를 얻었다는 데이터는
거의 없다.</p>
<p>따라서 클로자핀 저항성 환자라도 클로자핀을 끊지 않는 것이 보통이다.
대신 다양한 약물을 병용하게 되는데, 이 역시 확실한 결론이 나지 않았다.
몇몇 개방형 연구에서는 다른 항정신병 약물을 병용하여 치료 반응이
나아지기도 했지만, 이중맹검 연구만을 골라서 메타 분석을 해보았더니
유의한 차이가 드러나지 않았다.<span class="citation"
data-cites="RN288">(<a href="#ref-RN288" role="doc-biblioref">Barbui et
al. 2009</a>)</span> 또 다른 메타 분석에서는 항정신병 약물 다중 투여가
다소간 이점을 보이는 것으로 나타났으나 미미한 정도에 지나지 않았다.<span
class="citation" data-cites="RN289">(<a href="#ref-RN289"
role="doc-biblioref">Taylor et al. 2012</a>)</span> 가장 최근에 이루어진
이중맹검 연구를 대상으로 한 메타 분석에서도, 음성 증상과 우울 증상에
대해서만 다소 효과가 있었을 뿐, 양성 증상 호전에는 위약군과 차이가
없었다.<span class="citation" data-cites="RN292">(<a href="#ref-RN292"
role="doc-biblioref">Bartoli et al. 2019</a>)</span></p>
<p>한 가지 예외는 클로자핀과 아리피프라졸의 병용 투여이다. 두 약물은
작용기전이 전혀 다르기 때문에 일치감치 병용 투여 전략이 제안되었으며,
비교적 많은 이중 맹검 임상 시험이 진행되었다. 클로자핀 단독 투여군과
아리피프라졸 병용 투여군을 비교한 임상 연구를 메타 분석한 결과에 따르면,
분명 병용 투여군이 양성 증상을 비롯한 각 분야에서 우수한 반응을
보였다.<span class="citation" data-cites="Wagner2019">(<a
href="#ref-Wagner2019" role="doc-biblioref">Wagner et al.
2019</a>)</span> Tiihonen 등<span class="citation"
data-cites="Tiihonen2019">(<a href="#ref-Tiihonen2019"
role="doc-biblioref">Tiihonen et al. 2019</a>)</span>은 스웨덴 국가
데이터베이스를 이용하여 클로자핀을 포함한 다양한 항정신병 약물 다약제
투여 환자의 재입원률을 조사하였는데, 가장 재입원 위험이 낮았던 것은
클로자핀과 아리프프리졸을 병용 투여했던 환자들이었다. 이상과 같이
클로자핀 단독 치료에 비해 아리피프라졸 병용 투여가 좀더 효과적이었다는
보고가 많은데 비해, 다른 병용 투여 전략과 비교해서는 별반 이점이
없었다는 연구 결과도 있다. Clozapine Haloperidol Aripiprazole Trial
(CHAT)이라고 이름 붙여진 연구에서는 클로자핀 + 할로페리돌 군과 클로자핀
+ 아리피프라졸 군을 이중 맹검으로 비교하였는데, 후자가 내약성이 훨씬
우수했을 뿐 효과 면에서는 두 군이 별 차이를 보이지 않았다.[<span
class="citation" data-cites="Barbui2011">Barbui et al. (<a
href="#ref-Barbui2011" role="doc-biblioref">2011</a>)</span>]<span
class="citation" data-cites="Cipriani2013">(<a href="#ref-Cipriani2013"
role="doc-biblioref">Cipriani et al. 2013</a>)</span></p>
<p>항경련제 중에서 특히 클로자핀과의 병용 요법이 부각된 것은 전압의존
나트륨 채널 차단제인 라모트리진이다. 라모트리진은 Phencyclidine (PCP)
유발 정신병 모델에서 유의한 치료 효과를 나타내기 때문에<span
class="citation" data-cites="Quarta2011">(<a href="#ref-Quarta2011"
role="doc-biblioref">Quarta and Large 2010</a>)</span>, 일찍부터
치료저항성 조현병 환자에게 증강 치료로서 시도되었고 상당한 가능성을
보여왔다.<span class="citation" data-cites="Large2005">(<a
href="#ref-Large2005" role="doc-biblioref">Large, Webster, and Goff
2005</a>)</span> 캐나다의 정신과 의사 Dursun 등<span class="citation"
data-cites="Dursun1999">(<a href="#ref-Dursun1999"
role="doc-biblioref">Dursun, McIntosh, and Milliken 1999</a>)</span>이
6명의 클로자핀 저항성 환자에게 시도하여 성과를 얻은 후, 현재까지도
끊임없이 연구가 이어졌다. 2009년에는 첫번째 메타 분석결과가
발표되었는데, 음성 증상 및 양성 증상에서도 위약 대조군에 비해 우수한
성적을 보였다.<span class="citation" data-cites="Tiihonen2009">(<a
href="#ref-Tiihonen2009" role="doc-biblioref">Tiihonen, Wahlbeck, and
Kiviniemi 2009</a>)</span></p>
<p>토피라메이트 역시 유사한 항경련제로서 클로자핀 저항성 환자에게
시도되어 왔다. Zheng 등<span class="citation" data-cites="Zheng2017">(<a
href="#ref-Zheng2017" role="doc-biblioref">Zheng et al.
2017</a>)</span>은 클로자핀과 다양한 항경련제 병용 투여에 대한 메타 분석
결과을 발표하였는데, 여러 연구에서 비교적 일관되게 우수한 성적을 나타낸
것은 발프로에이트와 토피라메이트였다. 라모트리진도 일차 분석에서는
유효한 것으로 나타났으나, 지나치게 성적이 우수한 두 개의 연구를
제외하였더니 더 이상 유효하지 않은 것으로 나타나 제외된 두 연구 결과에
의구심을 불러 일으켰다. 그러나 의사들의 약물 사용 추세를 보면,
토피라메이트는 치료저항성을 해결하기 보다는 체중 증가, 당대사 호전,
다음증 등 부작용을 해결하기 위해 사용하는 경우가 많으며, 정작 효과
증진을 위해서는 라모트리진을 선호하는 편이다.</p>
<p>이 밖에도 항우울제나 글루타메이트 효현제 등을 병용 투여하기도 하는데,
이는 클로자핀 저항성을 해결한다기 보다는 클로자핀을 투여해도 여전히
미진해보이는 영역을 호전시키기 위해서 시도된다. 주로 음성 증상 및 인지
증상이 그 대상이 되는데, 얻어진 결과들이 썩 만족스럽지는 못하다.
항우울제는 클로자핀 투여에도 별반 변화되지 않은 음성 증상을 호전시키기
위해 활발하게 연구되었으나, 얻어진 결과는 초라하다. 플루옥세틴은 거의
효과가 없었으며, 시탈로프람은 중국에서 행해진 단 하나의 연구에서만
효과가 입증되었다. 미르타자핀의 경우 행해지 두 개의 연구가 상반된 결론을
내놓고 있어 결론이 나지 않았다.<span class="citation"
data-cites="Sommer2012">(<a href="#ref-Sommer2012"
role="doc-biblioref">Sommer et al. 2011</a>)</span> 이외에도 CX 516,
D-cycloserine, D-serine, glycine, sarcosine과 같은 글루타민계 약물도
클로자핀과 함께 투여되었으나 결과는 변변치 못했다.<span class="citation"
data-cites="Sommer2012">(<a href="#ref-Sommer2012"
role="doc-biblioref">Sommer et al. 2011</a>)</span></p>
<p>종합하면 클로자핀에 대해서도 효과를 보이지 않을 때 선택의 폭은
무척이나 좁혀진다. 아리피프라졸의 병용 투여를 제외하고는 근거중심
의학에서 요구하는 근거가 전혀 없는 상황이다. 하지만 여러가지 이유로
클로자핀을 충분히 쓸 수가 없을 때, 대안으로서 시도되는 다양한 전략이
예기치 않게 돌파구가 될 수도 있다. 예를 들어 Lowe 등<span
class="citation" data-cites="Lowe2018">(<a href="#ref-Lowe2018"
role="doc-biblioref">Lowe et al. 2017</a>)</span>은 심각한 부작용때문에
클로자핀을 사용할 수 없었던 환자에게 vortioxetine과 lurasidone을 함께
투여하여 눈에 띄는 효과를 보았던 증례를 보고하였다.</p>
<div class="sourceCode" id="cb1"><pre
class="sourceCode r distill-force-highlighting-css"><code class="sourceCode r"></code></pre></div>
<div id="refs" class="references csl-bib-body hanging-indent"
role="doc-bibliography">
<div id="ref-RN123" class="csl-entry" role="doc-biblioentry">
Agid, O., T. Arenovich, G. Sajeev, R. B. Zipursky, S. Kapur, G.
Foussias, and G. Remington. 2011. <span>“An Algorithm-Based Approach to
First-Episode Schizophrenia: Response Rates over 3 Prospective
Antipsychotic Trials with a Retrospective Data Analysis.”</span> <em>J
Clin Psychiatry</em> 72 (11): 1439–44. <a
href="https://doi.org/10.4088/JCP.09m05785yel">https://doi.org/10.4088/JCP.09m05785yel</a>.
</div>
<div id="ref-RN177" class="csl-entry" role="doc-biblioentry">
Alphs, Larry, Ravi Anand, M Zahur Islam, Herbert Y Meltzer, John M Kane,
Ranga Krishnan, Alan I Green, Steven Potkin, Guy Chouinard, and
Jean-Pierre Lindenmayer. 2004. <span>“The International Suicide
Prevention Trial (interSePT): Rationale and Design of a Trial Comparing
the Relative Ability of Clozapine and Olanzapine to Reduce Suicidal
Behavior in Schizophrenia and Schizoaffective Patients.”</span>
<em>Schizophrenia Bulletin</em> 30 (3): 577–86.
</div>
<div id="ref-RN281" class="csl-entry" role="doc-biblioentry">
Anderson, V. M., M. E. McIlwain, R. R. Kydd, and B. R. Russell. 2015.
<span>“Does Cognitive Impairment in Treatment-Resistant and
Ultra-Treatment-Resistant Schizophrenia Differ from That in Treatment
Responders?”</span> <em>Psychiatry Res</em> 230 (3): 811–18. <a
href="https://doi.org/10.1016/j.psychres.2015.10.036">https://doi.org/10.1016/j.psychres.2015.10.036</a>.
</div>
<div id="ref-RN276" class="csl-entry" role="doc-biblioentry">
Assion, H-J, H Reinbold, S Lemanski, M Basilowski, and G Juckel. 2008.
<span>“Amisulpride Augmentation in Patients with Schizophrenia Partially
Responsive or Unresponsive to Clozapine. A Randomized, Double-Blind,
Placebo-Controlled Trial.”</span> <em>Pharmacopsychiatry</em> 41 (01):
24–28.
</div>
<div id="ref-Barbui2011" class="csl-entry" role="doc-biblioentry">
Barbui, Corrado, Simone Accordini, Michela Nosè, Scott Stroup, Marianna
Purgato, Francesca Girlanda, Eleonora Esposito, Antonio Veronese,
Michele Tansella, and Andrea Cipriani. 2011. <span>“Aripiprazole Versus
Haloperidol in Combination With Clozapine for Treatment-Resistant
Schizophrenia in Routine Clinical Care.”</span> <em>Journal of Clinical
Psychopharmacology</em> 31 (3): 266–73. <a
href="https://doi.org/10.1097/jcp.0b013e318219cba3">https://doi.org/10.1097/jcp.0b013e318219cba3</a>.
</div>
<div id="ref-RN288" class="csl-entry" role="doc-biblioentry">
Barbui, Corrado, Alessandra Signoretti, Serena Mule, Marianna Boso, and
Andrea Cipriani. 2009. <span>“Does the Addition of a Second
Antipsychotic Drug Improve Clozapine Treatment?”</span>
<em>Schizophrenia Bulletin</em> 35 (2): 458–68.
</div>
<div id="ref-RN292" class="csl-entry" role="doc-biblioentry">
Bartoli, Francesco, Cristina Crocamo, Carmen Di Brita, Giovanni
Esposito, Tommaso Innocenzo Tabacchi, Enrica Verrengia, Massimo Clerici,
and Giuseppe Carra. 2019. <span>“Adjunctive Second-Generation
Antipsychotics for Specific Symptom Domains of Schizophrenia Resistant
to Clozapine: A Meta-Analysis.”</span> <em>Journal of Psychiatric
Research</em> 108: 24–33.
</div>
<div id="ref-RN189" class="csl-entry" role="doc-biblioentry">
Birchwood, Max, Pauline Todd, and Chris Jackson. 1998. <span>“Early
Intervention in Psychosis: The Critical Period Hypothesis.”</span>
<em>The British Journal of Psychiatry</em> 172 (S33): 53–59.
</div>
<div id="ref-RN269" class="csl-entry" role="doc-biblioentry">
Chan, Yiu-Chung, Karla M Miller, Natalie Shaheen, Nicholas A Votolato,
and Mary Beth Hankins. 2005. <span>“Worsening of Psychotic Symptoms in
Schizophrenia with Addition of Lamotrigine: A Case Report.”</span>
<em>Schizophrenia Research</em> 78 (2-3): 343.
</div>
<div id="ref-RN271" class="csl-entry" role="doc-biblioentry">
Chang, Jae Seung, Yongmin Ahn, Hye Jean Park, Kyu Young Lee, Se Hyun
Kim, Unggu Kang, and Yong Sik Kim. 2008. <span>“Aripiprazole
Augmentation in Clozapine-Treated Patients with Refractory
Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled
Trial.”</span> <em>Journal of Clinical Psychiatry</em> 69 (5): 720–31.
</div>
<div id="ref-Cipriani2013" class="csl-entry" role="doc-biblioentry">
Cipriani, Andrea, Simone Accordini, Michela Nosè, Marianna Purgato,
Francesca Girlanda, Michele Tansella, and Corrado Barbui. 2013.
<span>“Aripiprazole Versus Haloperidol in Combination With Clozapine for
Treatment-Resistant Schizophrenia.”</span> <em>Journal of Clinical
Psychopharmacology</em> 33 (4): 533–37. <a
href="https://doi.org/10.1097/jcp.0b013e318296884f">https://doi.org/10.1097/jcp.0b013e318296884f</a>.
</div>
<div id="ref-RN62" class="csl-entry" role="doc-biblioentry">
Demjaha, A., J. M. Lappin, D. Stahl, M. X. Patel, J. H. MacCabe, O. D.
Howes, M. Heslin, et al. 2017. <span>“Antipsychotic Treatment Resistance
in First-Episode Psychosis: Prevalence, Subtypes and Predictors.”</span>
<em>Psychol Med</em> 47 (11): 1981–89. <a
href="https://doi.org/10.1017/s0033291717000435">https://doi.org/10.1017/s0033291717000435</a>.
</div>
<div id="ref-Dossenbach2000" class="csl-entry" role="doc-biblioentry">
Dossenbach, Martin R.K., Jean-Noel Beuzen, Moshe Avnon, Robert H.
Belmaker, Avner Elizur, Mordechai Mark, Hanan Munitz, et al. 2000.
<span>“The Effectiveness of Olanzapine in Treatment-Refractory
Schizophrenia When Patients Are Nonresponsive to or Unable to Tolerate
Clozapine.”</span> <em>Clinical Therapeutics</em> 22 (9): 1021–34. <a
href="https://doi.org/10.1016/s0149-2918(00)80082-x">https://doi.org/10.1016/s0149-2918(00)80082-x</a>.
</div>
<div id="ref-Dursun1999" class="csl-entry" role="doc-biblioentry">
Dursun, Serdar M., Diane McIntosh, and Heather Milliken. 1999.
<span>“Clozapine Plus Lamotrigine in Treatment-Resistant
Schizophrenia.”</span> <em>Archives of General Psychiatry</em> 56 (10):
950. <a
href="https://doi.org/10.1001/archpsyc.56.10.950">https://doi.org/10.1001/archpsyc.56.10.950</a>.
</div>
<div id="ref-RN34" class="csl-entry" role="doc-biblioentry">
Faden, J., and L. Citrome. 2019. <span>“Resistance Is Not Futile:
Treatment-Refractory Schizophrenia - Overview, Evaluation and
Treatment.”</span> <em>Expert Opin Pharmacother</em> 20 (1): 11–24. <a
href="https://doi.org/10.1080/14656566.2018.1543409">https://doi.org/10.1080/14656566.2018.1543409</a>.
</div>
<div id="ref-Feeley2017" class="csl-entry" role="doc-biblioentry">
Feeley, Robert J., Bachaar Arnaout, and Gihyun Yoon. 2017.
<span>“Effective Switch From Clozapine to Aripiprazole in
Treatment-Resistant Schizophrenia and Comorbid Alcohol Use
Disorder.”</span> <em>Journal of Clinical Psychopharmacology</em> 37
(6): 729–30. <a
href="https://doi.org/10.1097/jcp.0000000000000794">https://doi.org/10.1097/jcp.0000000000000794</a>.
</div>
<div id="ref-RN182" class="csl-entry" role="doc-biblioentry">
Frogley, Catherine, David Taylor, Geoff Dickens, and Marco Picchioni.
2012. <span>“A Systematic Review of the Evidence of Clozapine’s
Anti-Aggressive Effects.”</span> <em>International Journal of
Neuropsychopharmacology</em> 15 (9): 1351–71.
</div>
<div id="ref-RN190" class="csl-entry" role="doc-biblioentry">
Garety, Philippa, and Suzanne Jolley. 2000. <span>“Early Intervention in
Psychosis.”</span> <em>Psychiatric Bulletin</em> 24 (9): 321–23.
</div>
<div id="ref-RN278" class="csl-entry" role="doc-biblioentry">
Goff, Donald C. 2009. <span>“Lamotrigine May Be an Effective Treatment
for Clozapine Resistant Schizophrenia.”</span> <em>Evidence-Based Mental
Health</em> 12 (4): 111.
</div>
<div id="ref-RN178" class="csl-entry" role="doc-biblioentry">
Hennen, John, and Ross J Baldessarini. 2005. <span>“Suicidal Risk During
Treatment with Clozapine: A Meta-Analysis.”</span> <em>Schizophrenia
Research</em> 73 (2-3): 139–45.
</div>
<div id="ref-RN275" class="csl-entry" role="doc-biblioentry">
Honer, William G, Allen E Thornton, Eric YH Chen, Raymond CK Chan,
Jessica OY Wong, Andrea Bergmann, Peter Falkai, Edith Pomarol-Clotet,
Peter J McKenna, and Emmanuel Stip. 2006. <span>“Clozapine Alone Versus
Clozapine and Risperidone with Refractory Schizophrenia.”</span> <em>New
England Journal of Medicine</em> 354 (5): 472–82.
</div>
<div id="ref-RN274" class="csl-entry" role="doc-biblioentry">
Josiassen, Richard C, Ashok Joseph, Eva Kohegyi, Sudhir Stokes, Mahmood
Dadvand, Wynn Wynn Paing, and Rita A Shaughnessy. 2005. <span>“Clozapine
Augmented with Risperidone in the Treatment of Schizophrenia: A
Randomized, Double-Blind, Placebo-Controlled Trial.”</span> <em>American
Journal of Psychiatry</em> 162 (1): 130–36.
</div>
<div id="ref-RN75" class="csl-entry" role="doc-biblioentry">
Kane, J. M., O. Agid, M. L. Baldwin, O. Howes, J. P. Lindenmayer, S.
Marder, M. Olfson, S. G. Potkin, and C. U. Correll. 2019.
<span>“Clinical Guidance on the Identification and Management of
Treatment-Resistant Schizophrenia.”</span> <em>J Clin Psychiatry</em> 80
(2). <a
href="https://doi.org/10.4088/JCP.18com12123">https://doi.org/10.4088/JCP.18com12123</a>.
</div>
<div id="ref-RN176" class="csl-entry" role="doc-biblioentry">
Kane, John, Gilbert Honigfeld, Jack Singer, and Herbert Meltzer. 1988.
<span>“Clozapine for the Treatment-Resistant Schizophrenic: A
Double-Blind Comparison with Chlorpromazine.”</span> <em>Archives of
General Psychiatry</em> 45 (9): 789–96.
</div>
<div id="ref-Kikuchi2014" class="csl-entry" role="doc-biblioentry">
Kikuchi, Yuka, Wataru Sato, Keiichiro Ataka, Kiwamu Yagisawa, Yuki
Omori, Takashi Kanbayashi, and Tetsuo Shimizu. 2014.
<span>“Clozapine-Induced Seizures, Electroencephalography Abnormalities,
and Clinical Responses in Japanese Patients with Schizophrenia.”</span>
<em>Neuropsychiatric Disease and Treatment</em>, October, 1973. <a
href="https://doi.org/10.2147/ndt.s69784">https://doi.org/10.2147/ndt.s69784</a>.
</div>
<div id="ref-RN175" class="csl-entry" role="doc-biblioentry">
Kolakowska, T, AO Williams, M Ardern, MA Reveley, K Jambor, MG Gelder,
and BM Mandelbrote. 1985. <span>“Schizophrenia with Good and Poor
Outcome. I: Early Clinical Features, Response to Neuroleptics and Signs
of Organic Dysfunction.”</span> <em>The British Journal of
Psychiatry</em> 146 (3): 229–39.
</div>
<div id="ref-RN122" class="csl-entry" role="doc-biblioentry">
Lally, J., O. Ajnakina, M. Di Forti, A. Trotta, A. Demjaha, A.
Kolliakou, V. Mondelli, et al. 2016. <span>“Two Distinct Patterns of
Treatment Resistance: Clinical Predictors of Treatment Resistance in
First-Episode Schizophrenia Spectrum Psychoses.”</span> <em>Psychol
Med</em> 46 (15): 3231–40. <a
href="https://doi.org/10.1017/s0033291716002014">https://doi.org/10.1017/s0033291716002014</a>.
</div>
<div id="ref-Large2005" class="csl-entry" role="doc-biblioentry">
Large, Charles H., Elizabeth L. Webster, and Donald C. Goff. 2005.
<span>“The Potential Role of Lamotrigine in Schizophrenia.”</span>
<em>Psychopharmacology</em> 181 (3): 415–36. <a
href="https://doi.org/10.1007/s00213-005-0020-9">https://doi.org/10.1007/s00213-005-0020-9</a>.
</div>
<div id="ref-RN280" class="csl-entry" role="doc-biblioentry">
Lee, Jimmy, Gagan Fervaha, Hiroyoshi Takeuchi, Valerie Powell, and Gary
Remington. 2015. <span>“Positive Symptoms Are Associated with
Clinicians’ Global Impression in Treatment-Resistant
Schizophrenia.”</span> <em>Journal of Clinical Psychopharmacology</em>
35 (3): 237–41.
</div>
<div id="ref-Lowe2018" class="csl-entry" role="doc-biblioentry">
Lowe, Penelope, Amir Krivoy, Lilla Porffy, Erna Henriksdottir, Whiskey
Eromona, and Sukhwinder S. Shergill. 2017. <span>“When the Drugs
Don<span>’</span>t Work: Treatment-Resistant Schizophrenia, Serotonin
and Serendipity.”</span> <em>Therapeutic Advances in
Psychopharmacology</em> 8 (1): 63–70. <a
href="https://doi.org/10.1177/2045125317737003">https://doi.org/10.1177/2045125317737003</a>.
</div>
<div id="ref-Martínez-Andrés2020" class="csl-entry"
role="doc-biblioentry">
Martínez-Andrés, Juan Andrés, and Juan Antonio García-Carmona. 2020.
<span>“Switching from Clozapine to Paliperidone Palmitate-3-Monthly
Improved Obesity, Hyperglycemia and Dyslipidemia Lowering Antipsychotic
Dose Equivalents in a Treatment-Resistant Schizophrenia Cohort.”</span>
<em>International Clinical Psychopharmacology</em> 35 (3): 163–69. <a
href="https://doi.org/10.1097/yic.0000000000000300">https://doi.org/10.1097/yic.0000000000000300</a>.
</div>
<div id="ref-RN173" class="csl-entry" role="doc-biblioentry">
McEvoy, Joseph P, Gerard E Hogarty, and Sandra Steingard. 1991.
<span>“Optimal Dose of Neuroleptic in Acute Schizophrenia: A Controlled
Study of the Neuroleptic Threshold and Higher Haloperidol Dose.”</span>
<em>Archives of General Psychiatry</em> 48 (8): 739–45.
</div>
<div id="ref-RN272" class="csl-entry" role="doc-biblioentry">
Mitsonis, Charalampos I, Nikolaos P Dimopoulos, Panagiotis A
Mitropoulos, Evangelia G Kararizou, Alexandra N Katsa, Fivos E Tsakiris,
and Maria Nefeli E Katsanou. 2007. <span>“Aripiprazole Augmentation in
the Management of Residual Symptoms in Clozapine-Treated Outpatients
with Chronic Schizophrenia: An Open-Label Pilot Study.”</span>
<em>Progress in Neuro-Psychopharmacology and Biological Psychiatry</em>
31 (2): 373–77.
</div>
<div id="ref-RN194" class="csl-entry" role="doc-biblioentry">
Miyamoto, Seiya, Lars Fredrik Jarskog, and W Wolfgang Fleischhacker.
2015. <span>“Schizophrenia: When Clozapine Fails.”</span> <em>Current
Opinion in Psychiatry</em> 28 (3): 243–48.
</div>
<div id="ref-RN266" class="csl-entry" role="doc-biblioentry">
Mouaffak, F., C. Tranulis, R. Gourevitch, M. F. Poirier, S. Douki, J. P.
Olié, H. Lôo, and D. Gourion. 2006. <span>“Augmentation Strategies of
Clozapine with Antipsychotics in the Treatment of Ultraresistant
Schizophrenia.”</span> <em>Clin Neuropharmacol</em> 29 (1): 28–33. <a
href="https://doi.org/10.1097/00002826-200601000-00009">https://doi.org/10.1097/00002826-200601000-00009</a>.
</div>
<div id="ref-RN193" class="csl-entry" role="doc-biblioentry">
Muscatello, Maria Rosaria A, Antonio Bruno, Pasquale De Fazio, Cristina
Segura-Garcia, Gianluca Pandolfo, and Rocco Zoccali. 2014.
<span>“Augmentation Strategies in Partial Responder and/or
Treatment-Resistant Schizophrenia Patients Treated with
Clozapine.”</span> <em>Expert Opinion on Pharmacotherapy</em> 15 (16):
2329–45.
</div>
<div id="ref-RN277" class="csl-entry" role="doc-biblioentry">
Paton, Carol, Craig Whittington, and Thomas R Barnes. 2007.
<span>“Augmentation with a Second Antipsychotic in Patients with
Schizophrenia Who Partially Respond to Clozapine: A
Meta-Analysis.”</span> <em>Journal of Clinical Psychopharmacology</em>
27 (2): 198–204.
</div>
<div id="ref-Quarta2011" class="csl-entry" role="doc-biblioentry">
Quarta, Davide, and Charles H Large. 2010. <span>“Effects of Lamotrigine
on PCP-Evoked Elevations in Monoamine Levels in the Medial Prefrontal
Cortex of Freely Moving Rats.”</span> <em>Journal of
Psychopharmacology</em> 25 (12): 1703–11. <a
href="https://doi.org/10.1177/0269881110385598">https://doi.org/10.1177/0269881110385598</a>.
</div>
<div id="ref-RN203" class="csl-entry" role="doc-biblioentry">
Remington, G., O. Agid, G. Foussias, M. Hahn, N. Rao, and M. Sinyor.
2013. <span>“Clozapine’s Role in the Treatment of First-Episode
Schizophrenia.”</span> <em>Am J Psychiatry</em> 170 (2): 146–51. <a
href="https://doi.org/10.1176/appi.ajp.2012.12060778">https://doi.org/10.1176/appi.ajp.2012.12060778</a>.
</div>
<div id="ref-Roberts2018" class="csl-entry" role="doc-biblioentry">
Roberts, Rossela, Abigail Neasham, Chania Lambrinudi, and Afshan Khan.
2018. <span>“A Quantitative Analysis of Antipsychotic Prescribing Trends
for the Treatment of Schizophrenia in England and Wales.”</span>
<em>JRSM Open</em> 9 (4): 205427041875857. <a
href="https://doi.org/10.1177/2054270418758570">https://doi.org/10.1177/2054270418758570</a>.
</div>
<div id="ref-RN352" class="csl-entry" role="doc-biblioentry">
Samara, Myrto T, Markus Dold, Myrsini Gianatsi, Adriani Nikolakopoulou,
Bartosz Helfer, Georgia Salanti, and Stefan Leucht. 2016.
<span>“Efficacy, Acceptability, and Tolerability of Antipsychotics in
Treatment-Resistant Schizophrenia: A Network Meta-Analysis.”</span>
<em>JAMA Psychiatry</em> 73 (3): 199–210.
</div>
<div id="ref-RN170" class="csl-entry" role="doc-biblioentry">
Siskind, Dan, Lara McCartney, Romi Goldschlager, and Steve Kisely. 2016.
<span>“Clozapine v. First-and Second-Generation Antipsychotics in
Treatment-Refractory Schizophrenia: Systematic Review and
Meta-Analysis.”</span> <em>The British Journal of Psychiatry</em> 209
(5): 385–92.
</div>
<div id="ref-RN168" class="csl-entry" role="doc-biblioentry">
Siskind, D., V. Siskind, and S. Kisely. 2017. <span>“Clozapine Response
Rates Among People with Treatment-Resistant Schizophrenia: Data from a
Systematic Review and Meta-Analysis.”</span> <em>Can J Psychiatry</em>
62 (11): 772–77. <a
href="https://doi.org/10.1177/0706743717718167">https://doi.org/10.1177/0706743717718167</a>.
</div>
<div id="ref-Sommer2012" class="csl-entry" role="doc-biblioentry">
Sommer, Iris E., Marieke J. H. Begemann, Anke Temmerman, and Stefan
Leucht. 2011. <span>“Pharmacological Augmentation Strategies for
Schizophrenia Patients With Insufficient Response to Clozapine: A
Quantitative Literature Review.”</span> <em>Schizophrenia Bulletin</em>
38 (5): 1003–11. <a
href="https://doi.org/10.1093/schbul/sbr004">https://doi.org/10.1093/schbul/sbr004</a>.
</div>
<div id="ref-Stahl2014" class="csl-entry" role="doc-biblioentry">
Stahl, Stephen M. 2014. <span>“Clozapine: Is Now the Time for More
Clinicians to Adopt This Orphan?”</span> <em>CNS Spectrums</em> 19 (4):
279–81. <a
href="https://doi.org/10.1017/s1092852914000418">https://doi.org/10.1017/s1092852914000418</a>.
</div>
<div id="ref-RN289" class="csl-entry" role="doc-biblioentry">
Taylor, DM, L Smith, SH Gee, and Jimmi Nielsen. 2012.
<span>“Augmentation of Clozapine with a Second Antipsychotic–a
Meta‐analysis.”</span> <em>Acta Psychiatrica Scandinavica</em> 125 (1):
15–24.
</div>
<div id="ref-Tiihonen2019" class="csl-entry" role="doc-biblioentry">
Tiihonen, Jari, Heidi Taipale, Juha Mehtälä, Pia Vattulainen, Christoph
U. Correll, and Antti Tanskanen. 2019. <span>“Association of
Antipsychotic Polypharmacy Vs Monotherapy With Psychiatric
Rehospitalization Among Adults With Schizophrenia.”</span> <em>JAMA
Psychiatry</em> 76 (5): 499. <a
href="https://doi.org/10.1001/jamapsychiatry.2018.4320">https://doi.org/10.1001/jamapsychiatry.2018.4320</a>.
</div>
<div id="ref-Tiihonen2009" class="csl-entry" role="doc-biblioentry">
Tiihonen, Jari, Kristian Wahlbeck, and Vesa Kiviniemi. 2009. <span>“The
Efficacy of Lamotrigine in Clozapine-Resistant Schizophrenia: A
Systematic Review and Meta-Analysis.”</span> <em>Schizophrenia
Research</em> 109 (1-3): 10–14. <a
href="https://doi.org/10.1016/j.schres.2009.01.002">https://doi.org/10.1016/j.schres.2009.01.002</a>.
</div>
<div id="ref-RN191" class="csl-entry" role="doc-biblioentry">
Üçok, Alp, Uğur Çikrikçili, Sercan Karabulut, Ada Salaj, Meliha Öztürk,
Öznur Tabak, and Rümeysa Durak. 2015. <span>“Delayed Initiation of
Clozapine May Be Related to Poor Response in Treatment-Resistant
Schizophrenia.”</span> <em>International Clinical
Psychopharmacology</em> 30 (5): 290–95.
</div>
<div id="ref-Wagner2019" class="csl-entry" role="doc-biblioentry">
Wagner, Elias, Lisa Löhrs, Dan Siskind, William G Honer, Peter Falkai,
and Alkomiet Hasan. 2019. <span>“Clozapine Augmentation Strategies
<span></span> a Systematic Meta-Review of Available Evidence. Treatment
Options for Clozapine Resistance.”</span> <em>Journal of
Psychopharmacology</em> 33 (4): 423–35. <a
href="https://doi.org/10.1177/0269881118822171">https://doi.org/10.1177/0269881118822171</a>.
</div>
<div id="ref-Warnez2014" class="csl-entry" role="doc-biblioentry">
Warnez, Stephanie, and Silvia Alessi-Severini. 2014. <span>“Clozapine: A
Review of Clinical Practice Guidelines and Prescribing Trends.”</span>
<em>BMC Psychiatry</em> 14 (1). <a
href="https://doi.org/10.1186/1471-244x-14-102">https://doi.org/10.1186/1471-244x-14-102</a>.
</div>
<div id="ref-RN172" class="csl-entry" role="doc-biblioentry">
Wiersma, Durk, Fokko J Nienhuis, Cees J Slooff, and Robert Giel. 1998.
<span>“Natural Course of Schizophrenic Disorders: A 15-Year Followup of
a Dutch Incidence Cohort.”</span> <em>Schizophrenia Bulletin</em> 24
(1): 75–85.
</div>
<div id="ref-Williams2015" class="csl-entry" role="doc-biblioentry">
Williams, Andrew M., and Susie H. Park. 2014. <span>“Seizure Associated
with Clozapine: Incidence, Etiology, and Management.”</span> <em>CNS
Drugs</em> 29 (2): 101–11. <a
href="https://doi.org/10.1007/s40263-014-0222-y">https://doi.org/10.1007/s40263-014-0222-y</a>.
</div>
<div id="ref-RN205" class="csl-entry" role="doc-biblioentry">
Wimberley, T., J. H. MacCabe, T. M. Laursen, H. J. Sørensen, A. Astrup,
H. T. Horsdal, C. Gasse, and H. Støvring. 2017. <span>“Mortality and
Self-Harm in Association with Clozapine in Treatment-Resistant
Schizophrenia.”</span> <em>Am J Psychiatry</em> 174 (10): 990–98. <a
href="https://doi.org/10.1176/appi.ajp.2017.16091097">https://doi.org/10.1176/appi.ajp.2017.16091097</a>.
</div>
<div id="ref-RN200" class="csl-entry" role="doc-biblioentry">
Yada, Yuji, Bunta Yoshimura, and Yoshiki Kishi. 2015. <span>“Correlation
Between Delay in Initiating Clozapine and Symptomatic
Improvement.”</span> <em>Schizophrenia Research</em> 168 (1-2): 585.
</div>
<div id="ref-Yamin2010" class="csl-entry" role="doc-biblioentry">
Yamin, Sami, and Krishna Vaddadi. 2010. <span>“Are We Using Excessive
Neuroleptics? An Argument for Systematic Neuroleptic Dose Reduction in
Stable Patients with Schizophrenia with Specific Reference to
Clozapine.”</span> <em>International Review of Psychiatry</em> 22 (2):
138–47. <a
href="https://doi.org/10.3109/09540261.2010.482558">https://doi.org/10.3109/09540261.2010.482558</a>.
</div>
<div id="ref-RN192" class="csl-entry" role="doc-biblioentry">
Yoshimura, Bunta, Yuji Yada, Ryuhei So, Manabu Takaki, and Norihito
Yamada. 2017. <span>“The Critical Treatment Window of Clozapine in
Treatment-Resistant Schizophrenia: Secondary Analysis of an
Observational Study.”</span> <em>Psychiatry Research</em> 250: 65–70.
</div>
<div id="ref-Zheng2017" class="csl-entry" role="doc-biblioentry">
Zheng, Wei, Yu-Tao Xiang, Xin-Hu Yang, Ying-Qiang Xiang, and Jose de
Leon. 2017. <span>“Clozapine Augmentation with Antiepileptic Drugs for
Treatment-Resistant Schizophrenia.”</span> <em>The Journal of Clinical
Psychiatry</em> 78 (5): e498–505. <a
href="https://doi.org/10.4088/jcp.16r10782">https://doi.org/10.4088/jcp.16r10782</a>.
</div>
</div>
<!--radix_placeholder_article_footer-->
<!--/radix_placeholder_article_footer-->
</div>

<div class="d-appendix">
</div>


<!--radix_placeholder_site_after_body-->
<!--/radix_placeholder_site_after_body-->
<!--radix_placeholder_appendices-->
<div class="appendix-bottom">
<h3 id="references">References</h3>
<div id="references-listing"></div>
</div>
<!--/radix_placeholder_appendices-->
<!--radix_placeholder_navigation_after_body-->
<!--/radix_placeholder_navigation_after_body-->

</body>

</html>
